Benign and malignant neoplastic processes arising from or involving components of the central, peripheral, and autonomic nervous systems, cranial nerves, and meninges. Included in this category are primary and metastatic nervous system neoplasms.
Neoplasms which arise from peripheral nerve tissue. This includes NEUROFIBROMAS; SCHWANNOMAS; GRANULAR CELL TUMORS; and malignant peripheral NERVE SHEATH NEOPLASMS. (From DeVita Jr et al., Cancer: Principles and Practice of Oncology, 5th ed, pp1750-1)
Benign and malignant neoplastic processes that arise from or secondarily involve the brain, spinal cord, or meninges.
Tumors or cancer of the DIGESTIVE SYSTEM.
The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges.
The entire nerve apparatus, composed of a central part, the brain and spinal cord, and a peripheral part, the cranial and spinal nerves, autonomic ganglia, and plexuses. (Stedman, 26th ed)
Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.
The nervous system outside of the brain and spinal cord. The peripheral nervous system has autonomic and somatic divisions. The autonomic nervous system includes the enteric, parasympathetic, and sympathetic subdivisions. The somatic nervous system includes the cranial and spinal nerves and their ganglia and the peripheral sensory receptors.
Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).
New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
Two ganglionated neural plexuses in the gut wall which form one of the three major divisions of the autonomic nervous system. The enteric nervous system innervates the gastrointestinal tract, the pancreas, and the gallbladder. It contains sensory neurons, interneurons, and motor neurons. Thus the circuitry can autonomously sense the tension and the chemical environment in the gut and regulate blood vessel tone, motility, secretions, and fluid transport. The system is itself governed by the central nervous system and receives both parasympathetic and sympathetic innervation. (From Kandel, Schwartz, and Jessel, Principles of Neural Science, 3d ed, p766)
Neoplasms containing cyst-like formations or producing mucin or serum.
The ENTERIC NERVOUS SYSTEM; PARASYMPATHETIC NERVOUS SYSTEM; and SYMPATHETIC NERVOUS SYSTEM taken together. Generally speaking, the autonomic nervous system regulates the internal environment during both peaceful activity and physical or emotional stress. Autonomic activity is controlled and integrated by the CENTRAL NERVOUS SYSTEM, especially the HYPOTHALAMUS and the SOLITARY NUCLEUS, which receive information relayed from VISCERAL AFFERENTS.
The thoracolumbar division of the autonomic nervous system. Sympathetic preganglionic fibers originate in neurons of the intermediolateral column of the spinal cord and project to the paravertebral and prevertebral ganglia, which in turn project to target organs. The sympathetic nervous system mediates the body's response to stressful situations, i.e., the fight or flight reactions. It often acts reciprocally to the parasympathetic system.
The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM.
Characteristic properties and processes of the NERVOUS SYSTEM as a whole or with reference to the peripheral or the CENTRAL NERVOUS SYSTEM.
Tumors or cancer of the SKIN.
Pathogenic infections of the brain, spinal cord, and meninges. DNA VIRUS INFECTIONS; RNA VIRUS INFECTIONS; BACTERIAL INFECTIONS; MYCOPLASMA INFECTIONS; SPIROCHAETALES INFECTIONS; fungal infections; PROTOZOAN INFECTIONS; HELMINTHIASIS; and PRION DISEASES may involve the central nervous system as a primary or secondary process.
Histochemical localization of immunoreactive substances using labeled antibodies as reagents.
Two or more abnormal growths of tissue occurring simultaneously and presumed to be of separate origin. The neoplasms may be histologically the same or different, and may be found in the same or different sites.
Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.
The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM.
Tumors or cancers of the KIDNEY.
Abnormal growths of tissue that follow a previous neoplasm but are not metastases of the latter. The second neoplasm may have the same or different histological type and can occur in the same or different organs as the previous neoplasm but in all cases arises from an independent oncogenic event. The development of the second neoplasm may or may not be related to the treatment for the previous neoplasm since genetic risk or predisposing factors may actually be the cause.
Tumors or cancer of the THYROID GLAND.
An adenocarcinoma producing mucin in significant amounts. (From Dorland, 27th ed)
Viral infections of the brain, spinal cord, meninges, or perimeningeal spaces.
Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE.
A cylindrical column of tissue that lies within the vertebral canal. It is composed of WHITE MATTER and GRAY MATTER.
DNA present in neoplastic tissue.
Tumors or cancer of the LUNG.
Tumors or cancer of the PAROTID GLAND.
A benign neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. In some instances, considerable portions of the neoplasm, or even the entire mass, may be cystic. (Stedman, 25th ed)
Neoplasms developing from some structure of the connective and subcutaneous tissue. The concept does not refer to neoplasms located in connective or soft tissue.
Tumors or cancer of the LIVER.
Neoplasms associated with a proliferation of a single clone of PLASMA CELLS and characterized by the secretion of PARAPROTEINS.
Tumors or cancer of the APPENDIX.
Inflammation of blood vessels within the central nervous system. Primary vasculitis is usually caused by autoimmune or idiopathic factors, while secondary vasculitis is caused by existing disease process. Clinical manifestations are highly variable but include HEADACHE; SEIZURES; behavioral alterations; INTRACRANIAL HEMORRHAGES; TRANSIENT ISCHEMIC ATTACK; and BRAIN INFARCTION. (From Adams et al., Principles of Neurology, 6th ed, pp856-61)
A general term for various neoplastic diseases of the lymphoid tissue.
'Nerve tissue proteins' are specialized proteins found within the nervous system's biological tissue, including neurofilaments, neuronal cytoskeletal proteins, and neural cell adhesion molecules, which facilitate structural support, intracellular communication, and synaptic connectivity essential for proper neurological function.
Tumors or cancer of the ENDOCRINE GLANDS.
Tumors or cancer of the EYE.
Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
The non-neuronal cells of the nervous system. They not only provide physical support, but also respond to injury, regulate the ionic and chemical composition of the extracellular milieu, participate in the BLOOD-BRAIN BARRIER and BLOOD-RETINAL BARRIER, form the myelin insulation of nervous pathways, guide neuronal migration during development, and exchange metabolites with neurons. Neuroglia have high-affinity transmitter uptake systems, voltage-dependent and transmitter-gated ion channels, and can release transmitters, but their role in signaling (as in many other functions) is unclear.
A multilocular tumor with mucin secreting epithelium. They are most often found in the ovary, but are also found in the pancreas, appendix, and rarely, retroperitoneal and in the urinary bladder. They are considered to have low-grade malignant potential.
Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms.
Benign and malignant neoplastic processes that arise from or secondarily involve the meningeal coverings of the brain and spinal cord.
Nerve fibers that are capable of rapidly conducting impulses away from the neuron cell body.
A class of drugs producing both physiological and psychological effects through a variety of mechanisms. They can be divided into "specific" agents, e.g., affecting an identifiable molecular mechanism unique to target cells bearing receptors for that agent, and "nonspecific" agents, those producing effects on different target cells and acting by diverse molecular mechanisms. Those with nonspecific mechanisms are generally further classed according to whether they produce behavioral depression or stimulation. Those with specific mechanisms are classed by locus of action or specific therapeutic use. (From Gilman AG, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p252)
Tumors or cancer of the GASTROINTESTINAL TRACT, from the MOUTH to the ANAL CANAL.
Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS.
A technique that localizes specific nucleic acid sequences within intact chromosomes, eukaryotic cells, or bacterial cells through the use of specific nucleic acid-labeled probes.
Tumors, cancer or other neoplasms produced by exposure to ionizing or non-ionizing radiation.
Neoplasms composed of vascular tissue. This concept does not refer to neoplasms located in blood vessels.
Benign and malignant neoplasms which occur within the substance of the spinal cord (intramedullary neoplasms) or in the space between the dura and spinal cord (intradural extramedullary neoplasms). The majority of intramedullary spinal tumors are primary CNS neoplasms including ASTROCYTOMA; EPENDYMOMA; and LIPOMA. Intramedullary neoplasms are often associated with SYRINGOMYELIA. The most frequent histologic types of intradural-extramedullary tumors are MENINGIOMA and NEUROFIBROMA.
Traumatic injuries to the brain, cranial nerves, spinal cord, autonomic nervous system, or neuromuscular system, including iatrogenic injuries induced by surgical procedures.
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
Tumors or cancer of the NOSE.

Use of positron emission tomography in evaluation of brachial plexopathy in breast cancer patients. (1/194)

18-Fluoro-2-deoxyglucose (FDG) positron emission tomography (PET) has previously been used successfully to image primary and metastatic breast cancer. In this pilot study, 19 breast cancer patients with symptoms/signs referrable to the brachial plexus were evaluated with 18FDG-PET. In 11 cases computerized tomography (CT) scanning was also performed. Of the 19 patients referred for PET study, 14 had abnormal uptake of 18FDG in the region of the symptomatic plexus. Four patients had normal PET studies and one had increased FDG uptake in the chest wall that accounted for her axillary pain. CT scans were performed in 9 of the 14 patients who had positive brachial plexus PET studies; six of these were either normal or showed no clear evidence of recurrent disease, while three CTs demonstrated clear brachial plexus involvement. Of two of the four patients with normal PET studies, one has had complete resolution of symptoms untreated while the other was found to have cervical disc herniation on magnetic resonance imaging (MRI) scan. The remaining two patients almost certainly had radiation-induced plexopathy and had normal CT, MRI and PET study. These data suggest that 18FDG-PET scanning is a useful tool in evaluation of patients with suspected metastatic plexopathy, particularly if other imaging studies are normal. It may also be useful in distinguishing between radiation-induced and metastatic plexopathy.  (+info)

TaqMan PCR-based gene dosage assay for predictive testing in individuals from a cancer family with INK4 locus haploinsufficiency. (2/194)

BACKGROUND: A genetic syndrome of cutaneous malignant melanoma and nervous system tumors recently has been characterized and shown to be linked to the INK4 locus in the 9p21 region. Hemizygosity at adjacent physically mapped microsatellite markers indicated deletion of p16, p19, and p15 clustered tumor suppressors. Because individuals from this family could benefit from predictive testing in terms of cancer prevention, we developed a direct test without need to analyze parental DNAs to comply with the rules of individual consent and secrecy. METHODS: We developed an assay using TaqManTM real-time quantitative PCR, with p15 as the test sequence and albumin (ALB) as the reference gene. The normalized ratio of p15/ALB is expected to yield a value of approximately 1 in individuals without the deletion, whereas a ratio of approximately 0.5, indicating p15 haploinsufficiency, is expected in predisposed individuals. RESULTS: All patients harboring the previously defined at-risk haplotype were correctly identified using this approach. In six individuals with deletions, the p15/ALB ratios were 0.472-0.556 (SD, 0.013-0.078). In the five individuals without deletions, the ratios were 0.919-1.019 (SD, 0.006-0.075). CONCLUSIONS: This is the first report of a high-throughput, automatable gene dosage assay successfully applied to the identification of a germ-line deletion. This approach, not limited by marker informativeness or the need for harvesting live cells, can be applied to any condition with haploinsufficiency and extended to the characterization of most abnormalities of the ploidy.  (+info)

Moderate dose-escalation of combination chemotherapy with concomitant thoracic radiotherapy in limited-disease small-cell lung cancer: prolonged intrathoracic tumor control and high central nervous system relapse rate. Groupe d'Oncologie-Pneumologie Clinique de l'Universite Catholique de Louvain, Brussels and Liege, Belgium. (3/194)

BACKGROUND: The role of chemotherapy dose-intensification in small-cell lung cancer (SCLC) remains unclear. This phase I-II study evaluates feasibility and outcome of combination chemotherapy at moderately elevated doses with concomitant thoracic radiotherapy in limited-disease SCLC. PATIENTS AND METHODS: Moderately elevated doses of ifosfamide-epirubicin (cycles 1 and 3) and of carboplatin-etoposide (cycles 2 and 4) were given with G-CSF and peripheral blood stem-cell (PBSC) support. Thoracic radiotherapy (40 Gy) was given once daily during the first five days of each cycle. RESULTS: Overall toxicity was acceptable; most common side-effects were myelosuppression and asthenia. All 35 eligible patients responded (23 CR, 12 PR). Median time to progression was 15 months: median overall survival was 24.6 months. Only 6 of 25 relapsing patients (24%) presented with a locoregional recurrence while 12 of 25 (48%) relapsed in the central nervous system (CNS). CONCLUSIONS: This regimen is a feasible dose-intensification with an acceptable toxicity profile. Its efficacy was demonstrated by a 100% response rate, an excellent local tumor control rate and a median survival of 24.6 months. In the absence of PCI, CNS relapse is a major problem if adequate local control is achieved.  (+info)

Site-specific epithelial-mesenchymal interactions in digestive neuroendocrine tumors. An experimental in vivo and in vitro study. (4/194)

Little is known about the functional interactions between digestive neuroendocrine tumor cells and their stromal microenvironment. The focus of our study is whether mesenchymal cells modulate peptide expression, cell proliferation, and invasiveness in digestive neuroendocrine tumor cells. We designed an experimental in vivo and in vitro study using the mouse enteroendocrine cell line STC-1. In vivo, STC-1 cells were injected subcutaneously in 18 immunosuppressed newborn rats. At day 21, all animals presented poorly differentiated neuroendocrine tumors with lung metastases. Subcutaneous tumors were usually limited by a capsule containing basement membrane components and myofibroblasts that presented a low mitotic index. Lung tumors were devoid of capsule and poor in myofibroblasts, and their mitotic index was high. The profile of peptide expression in STC-1 tumors was different from that of cultured STC-1 cells. In vitro, STC-1 cells were cultured with fibroblasts of different origins, including dermis, lung, digestive tract, and liver. Based on their origin, myofibroblasts differentially modulated hormone synthesis, proliferation, spreading, and adhesion of STC-1 cells. In conclusion, our results show that site-specific functional interactions between mesenchymal and neuroendocrine cells may contribute to modulating the behavior of digestive neuroendocrine tumors, depending on their growth site.  (+info)

Morphologic characterization of spontaneous nervous system tumors in mice and rats. (5/194)

Spontaneous rodent nervous system tumors, in comparison to those of man, are less well differentiated. Among the central nervous system (CNS) tumors, the "embryonic" forms (medulloblastoma, pineoblastoma) occur both in rodents and humans, whereas the human "adult" forms (gliomas, ependymomas, meningiomas) have fewer counterparts in rodents. In general, the incidence of spontaneous CNS tumors is higher in rats (>1%) than in mice (>0.001%). A characteristic rat CNS tumor is the granular cell tumor. Usually it is associated with the meninges, and most meningeal tumors in rats seem to be totally or at least partly composed of granular cells, which have eosinophilic granular cytoplasm, are periodic acid-Schiff reaction (PAS)-positive, and contain lysosomes. Such tumors are frequently found on the cerebellar surface or at the brain basis. Rat astrocytomas are diffuse, frequently multifocal, and they invade perivascular spaces and meninges. The neoplastic cells with round to oval nuclei and indistinct cytoplasm grow around preexisting neurons, producing satellitosis. In large tumors, there are necrotic areas surrounded by palisading cells. Extensive damage of brain tissue is associated with the presence of scavenger cells that react positively with histiocytic/macrophage markers. The neoplastic astrocytes do not stain positively for glial fibrillary acidic protein; they probably represent an immature phenotype. In contrast to neoplastic oligodendroglia, they bind the lectin RCA-1. Astrocytomas are frequently located in the brain stem, especially the basal ganglia. Rat oligodendroglial tumors are well circumscribed and frequently grow in the walls of brain ventricles. Their cells have water-clear cytoplasm and round, dark-staining nuclei. Atypical vascular endothelial proliferation occurs, especially at the tumor periphery. Occasionally in the oligodendrogliomas, primitive glial elements with large nuclei occur in the form of cell groups that form rows and circles. Primitive neuroectodermal tumors of rats, such as pineal tumors or medulloblastomas, appear to have features similar to those found in man. In mice, the meningeal tumors are mostly devoid of granular cells and the astrocytomas are similar to those occurring in rats, whereas spontaneous oligodendrogliomas are observed extremely rarely. Tumorlike lesions, such as lipomatous hamartomas or epidermoid cysts, are occasionally encountered in the mouse CNS. It is suggested that we classify rodent CNS lesions as "low grade" and "high grade" rather than as "benign" and "malignant." The size of CNS tumors is generally related to their malignancy. Tumors of the peripheral nervous system are schwannomas and neurofibromas or neurofibrosarcomas consisting of Schwann cells, fibroblasts, and perineural cells. Well-differentiated schwannomas are characterized by S-100 positivity and the presence of basement membrane. They show either Antoni A pattern with fusiform palisading cells or Antoni B pattern, which is sparsely cellular and has a clear matrix. The rat develops specific forms of schwannomas in the areas of the submandibular salivary gland, the external ear, the orbit, and the endocardium. Spontaneous ganglioneuromas occur in the rat adrenal medulla or thyroid gland. Compared to experimentally induced neoplasms, the spontaneous tumors of the rodent nervous system are poor and impractical models of human disease, although they may serve as general indicators of the carcinogenic potential of tested chemicals.  (+info)

Evaluation of ENU-induced gliomas in rats: nomenclature, immunochemistry, and malignancy. (6/194)

Rats developed mixed gliomas, oligodendrogliomas, and a few astrocytomas in response to transplacental ethylnitrosourea. The neoplastic cell composition of mixed gliomas must be defined; this study required a 20-80% admixture of neoplastic astrocytes and oligodendroglia for the diagnosis of mixed glioma. A battery of immunoantibodies, including Leu-7, S-100, and vimentin, were helpful in classifying rat gliomas, and the histologic features of each tumor type are described. Other brain tumor characteristics that may decide the outcome of carcinogenicity studies include incidence, multiplicity, latency, fatality, size, and malignancy. The size of tumors was determined by measuring their 3-dimensional volumes. Brain tumor volume was found to be highly correlated with malignancy and fatality. Systematic evaluation of the malignancy of brain tumors is an important but often overlooked adjunct method of measuring the effectiveness of a carcinogen. A system to estimate malignancy, one that grades 9 tumor characteristics and weights, each according to clinical outcome, was developed. It was found that mixed gliomas grew larger, had a shorter latency, and were significantly more malignant than were other gliomas.  (+info)

Tumors of the nervous system in carcinogenic hazard identification. (7/194)

In the absence of adequate data on humans, it is biologically plausible and prudent to regard agents and mixtures for which there is sufficient evidence of carcinogenicity in experimental animals, usually rats and mice, as if they presented a carcinogenic risk to humans. Prediction of cancer sites in humans from bioassay data in rodents is much less certain, however, regardless of organ or tissue. For tumors of the nervous system, there is practically no basis for judging the validity of such predictions, as only ionizing radiation is known to cause tumors of the central nervous system (CNS) in humans. Brain tumors are relatively uncommon findings in bioassays and are rare in untreated rodents, even in rats, which appear to be the most susceptible species. However, CNS tumors have been readily induced in rodents by systemic exposures to some chemicals, notably N-nitrosoalkylureas and other alkylating agents and certain alkyl hydrazine derivatives. CNS tumors in rodents have played a significant role in carcinogenic hazard evaluations of several other chemicals, including acrylonitrile, ethylene oxide, and acrylamide, and have been implicated as part of the tumor spectrum induced by vinyl chloride and certain inorganic lead compounds. In some of these evaluations, it is not certain that all tumors diagnosed as primary brain tumors were correctly identified. Diagnostic difficulties have been presented by undifferentiated small-cell tumors that may invade the brain, including carcinomas of the nasal cavity and undifferentiated schwannomas arising in cranial nerve ganglia, and by the difficulty of reliably distinguishing between focal reactive gliosis and early glial neoplasms. The most striking experimental finding regarding the induction by chemicals of tumors of the nervous system is the dramatically greater susceptibility of the fetal and neonatal nervous system to some carcinogens, as compared with the susceptibility of the nervous system in adults of the same species.  (+info)

Microsatellite instability and the PTEN1 gene mutation in a subset of early onset gliomas carrying germline mutation or promoter methylation of the hMLH1 gene. (8/194)

High-frequent microsatellite instability (MSI-H) was detected in two of the 80 gliomas examined, whlie the other 78 gliomas showed microsatellite stable (MSS) phenotype. Both of the two MSI-H tumors were glioblastomas which developed in teenage patients. One of the patient was diagnosed as having Turcot's syndrome and had a germline mutation in the hMLH1 gene. Loss of expression due to promoter methylation was selectively observed in the wild type allele of the hMLH1 gene in the tumor of this patient. The other patient had neither a family history nor a past personal history of malignancy. Although no mutation in the mismatch repair genes was detected in the tumor of this patient, the level of expression of the hMLH1 gene was markedly decreased and the promoter sequence of the gene was highly methylated. In the tumor of this patient, the PTEN1 gene, one of the genes carrying microsatellite sequences in their coding regions, was altered by a slippage mutation within five adenine repeat sequences. These findings indicate that the genetic or epigenentic inactivation of the hMLH1 gene is involved in a subset of early-onset gliomas and the PTEN1 gene could be a downstream target for mutation as observed in glioblastoma without MSI.  (+info)

Nervous system neoplasms are abnormal growths or tumors that occur within the nervous system, which includes the brain, spinal cord, and peripheral nerves. These tumors can be benign (non-cancerous) or malignant (cancerous), and their growth can compress or infiltrate surrounding tissues, leading to various neurological symptoms. The causes of nervous system neoplasms are not fully understood but may involve genetic factors, exposure to certain chemicals or radiation, and certain viral infections. Treatment options depend on the type, location, and size of the tumor and can include surgery, radiation therapy, chemotherapy, or a combination of these approaches.

Peripheral nervous system (PNS) neoplasms refer to tumors that originate in the peripheral nerves, which are the nerves outside the brain and spinal cord. These tumors can be benign or malignant (cancerous). Benign tumors, such as schwannomas and neurofibromas, grow slowly and do not spread to other parts of the body. Malignant tumors, such as malignant peripheral nerve sheath tumors (MPNSTs), can invade nearby tissues and may metastasize (spread) to other organs.

PNS neoplasms can cause various symptoms depending on their location and size. Common symptoms include pain, weakness, numbness, or tingling in the affected area. In some cases, PNS neoplasms may not cause any symptoms until they become quite large. Treatment options for PNS neoplasms depend on several factors, including the type, size, and location of the tumor, as well as the patient's overall health. Treatment options may include surgery, radiation therapy, chemotherapy, or a combination of these approaches.

Central nervous system (CNS) neoplasms refer to a group of abnormal growths or tumors that develop within the brain or spinal cord. These tumors can be benign or malignant, and their growth can compress or disrupt the normal functioning of surrounding brain or spinal cord tissue.

Benign CNS neoplasms are slow-growing and rarely spread to other parts of the body. However, they can still cause significant problems if they grow large enough to put pressure on vital structures within the brain or spinal cord. Malignant CNS neoplasms, on the other hand, are aggressive tumors that can invade and destroy surrounding tissue. They may also spread to other parts of the CNS or, rarely, to other organs in the body.

CNS neoplasms can arise from various types of cells within the brain or spinal cord, including nerve cells, glial cells (which provide support and insulation for nerve cells), and supportive tissues such as blood vessels. The specific type of CNS neoplasm is often used to help guide treatment decisions and determine prognosis.

Symptoms of CNS neoplasms can vary widely depending on the location and size of the tumor, but may include headaches, seizures, weakness or paralysis, vision or hearing changes, balance problems, memory loss, and changes in behavior or personality. Treatment options for CNS neoplasms may include surgery, radiation therapy, chemotherapy, or a combination of these approaches.

'Digestive System Neoplasms' refer to new and abnormal growths of tissue in the digestive system that can be benign or malignant. These growths are also known as tumors, and they can occur in any part of the digestive system, including the esophagus, stomach, small intestine, large intestine (colon and rectum), liver, bile ducts, pancreas, and gallbladder. Neoplasms in the digestive system can interfere with normal digestion and absorption of nutrients, cause bleeding, obstruct the digestive tract, and spread to other parts of the body (metastasis) if they are malignant.

Benign neoplasms are not cancerous and do not usually spread to other parts of the body. They can often be removed surgically and may not require further treatment. Malignant neoplasms, on the other hand, are cancerous and can invade nearby tissues and organs and spread to other parts of the body. Treatment for malignant neoplasms in the digestive system typically involves a combination of surgery, radiation therapy, and chemotherapy.

The causes of digestive system neoplasms are varied and include genetic factors, environmental exposures, lifestyle factors (such as diet and smoking), and infectious agents. Prevention strategies may include maintaining a healthy diet, avoiding tobacco and excessive alcohol consumption, practicing safe sex, getting vaccinated against certain viral infections, and undergoing regular screenings for certain types of neoplasms (such as colonoscopies for colorectal cancer).

The Central Nervous System (CNS) is the part of the nervous system that consists of the brain and spinal cord. It is called the "central" system because it receives information from, and sends information to, the rest of the body through peripheral nerves, which make up the Peripheral Nervous System (PNS).

The CNS is responsible for processing sensory information, controlling motor functions, and regulating various autonomic processes like heart rate, respiration, and digestion. The brain, as the command center of the CNS, interprets sensory stimuli, formulates thoughts, and initiates actions. The spinal cord serves as a conduit for nerve impulses traveling to and from the brain and the rest of the body.

The CNS is protected by several structures, including the skull (which houses the brain) and the vertebral column (which surrounds and protects the spinal cord). Despite these protective measures, the CNS remains vulnerable to injury and disease, which can have severe consequences due to its crucial role in controlling essential bodily functions.

The nervous system is a complex, highly organized network of specialized cells called neurons and glial cells that communicate with each other via electrical and chemical signals to coordinate various functions and activities in the body. It consists of two main parts: the central nervous system (CNS), including the brain and spinal cord, and the peripheral nervous system (PNS), which includes all the nerves and ganglia outside the CNS.

The primary function of the nervous system is to receive, process, and integrate information from both internal and external environments and then respond by generating appropriate motor outputs or behaviors. This involves sensing various stimuli through specialized receptors, transmitting this information through afferent neurons to the CNS for processing, integrating this information with other inputs and memories, making decisions based on this processed information, and finally executing responses through efferent neurons that control effector organs such as muscles and glands.

The nervous system can be further divided into subsystems based on their functions, including the somatic nervous system, which controls voluntary movements and reflexes; the autonomic nervous system, which regulates involuntary physiological processes like heart rate, digestion, and respiration; and the enteric nervous system, which is a specialized subset of the autonomic nervous system that controls gut functions. Overall, the nervous system plays a critical role in maintaining homeostasis, regulating behavior, and enabling cognition and consciousness.

Central nervous system (CNS) diseases refer to medical conditions that primarily affect the brain and spinal cord. The CNS is responsible for controlling various functions in the body, including movement, sensation, cognition, and behavior. Therefore, diseases of the CNS can have significant impacts on a person's quality of life and overall health.

There are many different types of CNS diseases, including:

1. Infectious diseases: These are caused by viruses, bacteria, fungi, or parasites that infect the brain or spinal cord. Examples include meningitis, encephalitis, and polio.
2. Neurodegenerative diseases: These are characterized by progressive loss of nerve cells in the brain or spinal cord. Examples include Alzheimer's disease, Parkinson's disease, and Huntington's disease.
3. Structural diseases: These involve damage to the physical structure of the brain or spinal cord, such as from trauma, tumors, or stroke.
4. Functional diseases: These affect the function of the nervous system without obvious structural damage, such as multiple sclerosis and epilepsy.
5. Genetic disorders: Some CNS diseases are caused by genetic mutations, such as spinal muscular atrophy and Friedreich's ataxia.

Symptoms of CNS diseases can vary widely depending on the specific condition and the area of the brain or spinal cord that is affected. They may include muscle weakness, paralysis, seizures, loss of sensation, difficulty with coordination and balance, confusion, memory loss, changes in behavior or mood, and pain. Treatment for CNS diseases depends on the specific condition and may involve medications, surgery, rehabilitation therapy, or a combination of these approaches.

The Peripheral Nervous System (PNS) is that part of the nervous system which lies outside of the brain and spinal cord. It includes all the nerves and ganglia ( clusters of neurons) outside of the central nervous system (CNS). The PNS is divided into two components: the somatic nervous system and the autonomic nervous system.

The somatic nervous system is responsible for transmitting sensory information from the skin, muscles, and joints to the CNS, and for controlling voluntary movements of the skeletal muscles.

The autonomic nervous system, on the other hand, controls involuntary actions, such as heart rate, digestion, respiratory rate, salivation, perspiration, pupillary dilation, and sexual arousal. It is further divided into the sympathetic and parasympathetic systems, which generally have opposing effects and maintain homeostasis in the body.

Damage to the peripheral nervous system can result in various medical conditions such as neuropathies, neuritis, plexopathies, and radiculopathies, leading to symptoms like numbness, tingling, pain, weakness, or loss of reflexes in the affected area.

Pancreatic neoplasms refer to abnormal growths in the pancreas that can be benign or malignant. The pancreas is a gland located behind the stomach that produces hormones and digestive enzymes. Pancreatic neoplasms can interfere with the normal functioning of the pancreas, leading to various health complications.

Benign pancreatic neoplasms are non-cancerous growths that do not spread to other parts of the body. They are usually removed through surgery to prevent any potential complications, such as blocking the bile duct or causing pain.

Malignant pancreatic neoplasms, also known as pancreatic cancer, are cancerous growths that can invade and destroy surrounding tissues and organs. They can also spread (metastasize) to other parts of the body, such as the liver, lungs, or bones. Pancreatic cancer is often aggressive and difficult to treat, with a poor prognosis.

There are several types of pancreatic neoplasms, including adenocarcinomas, neuroendocrine tumors, solid pseudopapillary neoplasms, and cystic neoplasms. The specific type of neoplasm is determined through various diagnostic tests, such as imaging studies, biopsies, and blood tests. Treatment options depend on the type, stage, and location of the neoplasm, as well as the patient's overall health and preferences.

Neoplasms are abnormal growths of cells or tissues in the body that serve no physiological function. They can be benign (non-cancerous) or malignant (cancerous). Benign neoplasms are typically slow growing and do not spread to other parts of the body, while malignant neoplasms are aggressive, invasive, and can metastasize to distant sites.

Neoplasms occur when there is a dysregulation in the normal process of cell division and differentiation, leading to uncontrolled growth and accumulation of cells. This can result from genetic mutations or other factors such as viral infections, environmental exposures, or hormonal imbalances.

Neoplasms can develop in any organ or tissue of the body and can cause various symptoms depending on their size, location, and type. Treatment options for neoplasms include surgery, radiation therapy, chemotherapy, immunotherapy, and targeted therapy, among others.

The enteric nervous system (ENS) is a part of the autonomic nervous system that directly controls the gastrointestinal tract, including the stomach, small intestine, colon, and rectum. It is sometimes referred to as the "second brain" because it can operate independently of the central nervous system (CNS).

The ENS contains around 500 million neurons that are organized into two main plexuses: the myenteric plexus, which lies between the longitudinal and circular muscle layers of the gut, and the submucosal plexus, which is located in the submucosa. These plexuses contain various types of neurons that are responsible for regulating gastrointestinal motility, secretion, and blood flow.

The ENS can communicate with the CNS through afferent nerve fibers that transmit information about the state of the gut to the brain, and efferent nerve fibers that carry signals from the brain back to the ENS. However, the ENS is also capable of functioning independently of the CNS, allowing it to regulate gastrointestinal functions in response to local stimuli such as food intake, inflammation, or infection.

Neoplasms: Neoplasms refer to abnormal growths of tissue that can be benign (non-cancerous) or malignant (cancerous). They occur when the normal control mechanisms that regulate cell growth and division are disrupted, leading to uncontrolled cell proliferation.

Cystic Neoplasms: Cystic neoplasms are tumors that contain fluid-filled sacs or cysts. These tumors can be benign or malignant and can occur in various organs of the body, including the pancreas, ovary, and liver.

Mucinous Neoplasms: Mucinous neoplasms are a type of cystic neoplasm that is characterized by the production of mucin, a gel-like substance produced by certain types of cells. These tumors can occur in various organs, including the ovary, pancreas, and colon. Mucinous neoplasms can be benign or malignant, and malignant forms are often aggressive and have a poor prognosis.

Serous Neoplasms: Serous neoplasms are another type of cystic neoplasm that is characterized by the production of serous fluid, which is a thin, watery fluid. These tumors commonly occur in the ovary and can be benign or malignant. Malignant serous neoplasms are often aggressive and have a poor prognosis.

In summary, neoplasms refer to abnormal tissue growths that can be benign or malignant. Cystic neoplasms contain fluid-filled sacs and can occur in various organs of the body. Mucinous neoplasms produce a gel-like substance called mucin and can also occur in various organs, while serous neoplasms produce thin, watery fluid and commonly occur in the ovary. Both mucinous and serous neoplasms can be benign or malignant, with malignant forms often being aggressive and having a poor prognosis.

The Autonomic Nervous System (ANS) is a part of the peripheral nervous system that operates largely below the level of consciousness and controls visceral functions. It is divided into two main subdivisions: the sympathetic and parasympathetic nervous systems, which generally have opposing effects and maintain homeostasis in the body.

The Sympathetic Nervous System (SNS) prepares the body for stressful or emergency situations, often referred to as the "fight or flight" response. It increases heart rate, blood pressure, respiratory rate, and metabolic rate, while also decreasing digestive activity. This response helps the body respond quickly to perceived threats.

The Parasympathetic Nervous System (PNS), on the other hand, promotes the "rest and digest" state, allowing the body to conserve energy and restore itself after the stress response has subsided. It decreases heart rate, blood pressure, and respiratory rate, while increasing digestive activity and promoting relaxation.

These two systems work together to maintain balance in the body by adjusting various functions based on internal and external demands. Disorders of the Autonomic Nervous System can lead to a variety of symptoms, such as orthostatic hypotension, gastroparesis, and cardiac arrhythmias, among others.

The sympathetic nervous system (SNS) is a part of the autonomic nervous system that operates largely below the level of consciousness, and it functions to produce appropriate physiological responses to perceived danger. It's often associated with the "fight or flight" response. The SNS uses nerve impulses to stimulate target organs, causing them to speed up (e.g., increased heart rate), prepare for action, or otherwise respond to stressful situations.

The sympathetic nervous system is activated due to stressful emotional or physical situations and it prepares the body for immediate actions. It dilates the pupils, increases heart rate and blood pressure, accelerates breathing, and slows down digestion. The primary neurotransmitter involved in this system is norepinephrine (also known as noradrenaline).

The brain is the central organ of the nervous system, responsible for receiving and processing sensory information, regulating vital functions, and controlling behavior, movement, and cognition. It is divided into several distinct regions, each with specific functions:

1. Cerebrum: The largest part of the brain, responsible for higher cognitive functions such as thinking, learning, memory, language, and perception. It is divided into two hemispheres, each controlling the opposite side of the body.
2. Cerebellum: Located at the back of the brain, it is responsible for coordinating muscle movements, maintaining balance, and fine-tuning motor skills.
3. Brainstem: Connects the cerebrum and cerebellum to the spinal cord, controlling vital functions such as breathing, heart rate, and blood pressure. It also serves as a relay center for sensory information and motor commands between the brain and the rest of the body.
4. Diencephalon: A region that includes the thalamus (a major sensory relay station) and hypothalamus (regulates hormones, temperature, hunger, thirst, and sleep).
5. Limbic system: A group of structures involved in emotional processing, memory formation, and motivation, including the hippocampus, amygdala, and cingulate gyrus.

The brain is composed of billions of interconnected neurons that communicate through electrical and chemical signals. It is protected by the skull and surrounded by three layers of membranes called meninges, as well as cerebrospinal fluid that provides cushioning and nutrients.

'Nervous system physiological phenomena' refer to the functions, activities, and processes that occur within the nervous system in a healthy or normal state. This includes:

1. Neuronal Activity: The transmission of electrical signals (action potentials) along neurons, which allows for communication between different cells and parts of the nervous system.

2. Neurotransmission: The release and binding of neurotransmitters to receptors on neighboring cells, enabling the transfer of information across the synapse or junction between two neurons.

3. Sensory Processing: The conversion of external stimuli into electrical signals by sensory receptors, followed by the transmission and interpretation of these signals within the central nervous system (brain and spinal cord).

4. Motor Function: The generation and execution of motor commands, allowing for voluntary movement and control of muscles and glands.

5. Autonomic Function: The regulation of internal organs and glands through the sympathetic and parasympathetic divisions of the autonomic nervous system, maintaining homeostasis within the body.

6. Cognitive Processes: Higher brain functions such as perception, attention, memory, language, learning, and emotion, which are supported by complex neural networks and interactions.

7. Sleep-Wake Cycle: The regulation of sleep and wakefulness through interactions between the brainstem, thalamus, hypothalamus, and basal forebrain, ensuring proper rest and recovery.

8. Development and Plasticity: The growth, maturation, and adaptation of the nervous system throughout life, including processes such as neuronal migration, synaptogenesis, and neural plasticity.

9. Endocrine Regulation: The interaction between the nervous system and endocrine system, with the hypothalamus playing a key role in controlling hormone release and maintaining homeostasis.

10. Immune Function: The communication between the nervous system and immune system, allowing for the coordination of responses to infection, injury, or stress.

Skin neoplasms refer to abnormal growths or tumors in the skin that can be benign (non-cancerous) or malignant (cancerous). They result from uncontrolled multiplication of skin cells, which can form various types of lesions. These growths may appear as lumps, bumps, sores, patches, or discolored areas on the skin.

Benign skin neoplasms include conditions such as moles, warts, and seborrheic keratoses, while malignant skin neoplasms are primarily classified into melanoma, squamous cell carcinoma, and basal cell carcinoma. These three types of cancerous skin growths are collectively known as non-melanoma skin cancers (NMSCs). Melanoma is the most aggressive and dangerous form of skin cancer, while NMSCs tend to be less invasive but more common.

It's essential to monitor any changes in existing skin lesions or the appearance of new growths and consult a healthcare professional for proper evaluation and treatment if needed.

Central nervous system (CNS) infections refer to infectious processes that affect the brain, spinal cord, and their surrounding membranes, known as meninges. These infections can be caused by various microorganisms, including bacteria, viruses, fungi, and parasites. Examples of CNS infections are:

1. Meningitis: Inflammation of the meninges, usually caused by bacterial or viral infections. Bacterial meningitis is a medical emergency that requires immediate treatment.
2. Encephalitis: Inflammation of the brain parenchyma, often caused by viral infections. Some viruses associated with encephalitis include herpes simplex virus, enteroviruses, and arboviruses.
3. Meningoencephalitis: A combined inflammation of both the brain and meninges, commonly seen in certain viral infections or when bacterial pathogens directly invade the brain.
4. Brain abscess: A localized collection of pus within the brain caused by a bacterial or fungal infection.
5. Spinal epidural abscess: An infection in the space surrounding the spinal cord, usually caused by bacteria.
6. Myelitis: Inflammation of the spinal cord, which can result from viral, bacterial, or fungal infections.
7. Rarely, parasitic infections like toxoplasmosis and cysticercosis can also affect the CNS.

Symptoms of CNS infections may include fever, headache, stiff neck, altered mental status, seizures, focal neurological deficits, or meningeal signs (e.g., Brudzinski's and Kernig's signs). The specific symptoms depend on the location and extent of the infection, as well as the causative organism. Prompt diagnosis and treatment are crucial to prevent long-term neurological complications or death.

Immunohistochemistry (IHC) is a technique used in pathology and laboratory medicine to identify specific proteins or antigens in tissue sections. It combines the principles of immunology and histology to detect the presence and location of these target molecules within cells and tissues. This technique utilizes antibodies that are specific to the protein or antigen of interest, which are then tagged with a detection system such as a chromogen or fluorophore. The stained tissue sections can be examined under a microscope, allowing for the visualization and analysis of the distribution and expression patterns of the target molecule in the context of the tissue architecture. Immunohistochemistry is widely used in diagnostic pathology to help identify various diseases, including cancer, infectious diseases, and immune-mediated disorders.

Multiple primary neoplasms refer to the occurrence of more than one primary malignant tumor in an individual, where each tumor is unrelated to the other and originates from separate cells or organs. This differs from metastatic cancer, where a single malignancy spreads to multiple sites in the body. Multiple primary neoplasms can be synchronous (occurring at the same time) or metachronous (occurring at different times). The risk of developing multiple primary neoplasms increases with age and is associated with certain genetic predispositions, environmental factors, and lifestyle choices such as smoking and alcohol consumption.

Nervous system diseases, also known as neurological disorders, refer to a group of conditions that affect the nervous system, which includes the brain, spinal cord, nerves, and muscles. These diseases can affect various functions of the body, such as movement, sensation, cognition, and behavior. They can be caused by genetics, infections, injuries, degeneration, or tumors. Examples of nervous system diseases include Alzheimer's disease, Parkinson's disease, multiple sclerosis, epilepsy, migraine, stroke, and neuroinfections like meningitis and encephalitis. The symptoms and severity of these disorders can vary widely, ranging from mild to severe and debilitating.

Neurons, also known as nerve cells or neurocytes, are specialized cells that constitute the basic unit of the nervous system. They are responsible for receiving, processing, and transmitting information and signals within the body. Neurons have three main parts: the dendrites, the cell body (soma), and the axon. The dendrites receive signals from other neurons or sensory receptors, while the axon transmits these signals to other neurons, muscles, or glands. The junction between two neurons is called a synapse, where neurotransmitters are released to transmit the signal across the gap (synaptic cleft) to the next neuron. Neurons vary in size, shape, and structure depending on their function and location within the nervous system.

Kidney neoplasms refer to abnormal growths or tumors in the kidney tissues that can be benign (non-cancerous) or malignant (cancerous). These growths can originate from various types of kidney cells, including the renal tubules, glomeruli, and the renal pelvis.

Malignant kidney neoplasms are also known as kidney cancers, with renal cell carcinoma being the most common type. Benign kidney neoplasms include renal adenomas, oncocytomas, and angiomyolipomas. While benign neoplasms are generally not life-threatening, they can still cause problems if they grow large enough to compromise kidney function or if they undergo malignant transformation.

Early detection and appropriate management of kidney neoplasms are crucial for improving patient outcomes and overall prognosis. Regular medical check-ups, imaging studies, and urinalysis can help in the early identification of these growths, allowing for timely intervention and treatment.

A "second primary neoplasm" is a distinct, new cancer or malignancy that develops in a person who has already had a previous cancer. It is not a recurrence or metastasis of the original tumor, but rather an independent cancer that arises in a different location or organ system. The development of second primary neoplasms can be influenced by various factors such as genetic predisposition, environmental exposures, and previous treatments like chemotherapy or radiation therapy.

It is important to note that the definition of "second primary neoplasm" may vary slightly depending on the specific source or context. In general medical usage, it refers to a new, separate cancer; however, in some research or clinical settings, there might be more precise criteria for defining and diagnosing second primary neoplasms.

Thyroid neoplasms refer to abnormal growths or tumors in the thyroid gland, which can be benign (non-cancerous) or malignant (cancerous). These growths can vary in size and may cause a noticeable lump or nodule in the neck. Thyroid neoplasms can also affect the function of the thyroid gland, leading to hormonal imbalances and related symptoms. The exact causes of thyroid neoplasms are not fully understood, but risk factors include radiation exposure, family history, and certain genetic conditions. It is important to note that most thyroid nodules are benign, but a proper medical evaluation is necessary to determine the nature of the growth and develop an appropriate treatment plan.

Adenocarcinoma, mucinous is a type of cancer that begins in the glandular cells that line certain organs and produce mucin, a substance that lubricates and protects tissues. This type of cancer is characterized by the presence of abundant pools of mucin within the tumor. It typically develops in organs such as the colon, rectum, lungs, pancreas, and ovaries.

Mucinous adenocarcinomas tend to have a distinct appearance under the microscope, with large pools of mucin pushing aside the cancer cells. They may also have a different clinical behavior compared to other types of adenocarcinomas, such as being more aggressive or having a worse prognosis in some cases.

It is important to note that while a diagnosis of adenocarcinoma, mucinous can be serious, the prognosis and treatment options may vary depending on several factors, including the location of the cancer, the stage at which it was diagnosed, and the individual's overall health.

Central nervous system (CNS) viral diseases refer to medical conditions caused by the infection and replication of viruses within the brain or spinal cord. These viruses can cause a range of symptoms, depending on the specific virus and the location of the infection within the CNS. Some common examples of CNS viral diseases include:

1. Meningitis: This is an inflammation of the membranes surrounding the brain and spinal cord (meninges) caused by viruses such as enteroviruses, herpes simplex virus, or HIV. Symptoms may include fever, headache, stiff neck, and altered mental status.
2. Encephalitis: This is an inflammation of the brain parenchyma caused by viruses such as herpes simplex virus, West Nile virus, or rabies virus. Symptoms may include fever, headache, confusion, seizures, and focal neurologic deficits.
3. Poliomyelitis: This is a highly infectious disease caused by the poliovirus that can lead to paralysis of the muscles used for breathing, swallowing, and movement. It primarily affects children under 5 years old.
4. HIV-associated neurological disorders (HAND): HIV can cause various neurologic symptoms such as cognitive impairment, peripheral neuropathy, and myopathy.
5. Progressive multifocal leukoencephalopathy (PML): This is a rare but serious demyelinating disease of the CNS caused by the JC virus that primarily affects individuals with weakened immune systems, such as those with HIV/AIDS or those receiving immunosuppressive therapy.

Treatment for CNS viral diseases depends on the specific virus and may include antiviral medications, supportive care, and management of symptoms. Prevention measures such as vaccination, avoiding contact with infected individuals, and practicing good hygiene can help reduce the risk of these infections.

Myeloproliferative disorders (MPDs) are a group of rare, chronic blood cancers that originate from the abnormal proliferation or growth of one or more types of blood-forming cells in the bone marrow. These disorders result in an overproduction of mature but dysfunctional blood cells, which can lead to serious complications such as blood clots, bleeding, and organ damage.

There are several subtypes of MPDs, including:

1. Chronic Myeloid Leukemia (CML): A disorder characterized by the overproduction of mature granulocytes (a type of white blood cell) in the bone marrow, leading to an increased number of these cells in the blood. CML is caused by a genetic mutation that results in the formation of the BCR-ABL fusion protein, which drives uncontrolled cell growth and division.
2. Polycythemia Vera (PV): A disorder characterized by the overproduction of all three types of blood cells - red blood cells, white blood cells, and platelets - in the bone marrow. This can lead to an increased risk of blood clots, bleeding, and enlargement of the spleen.
3. Essential Thrombocythemia (ET): A disorder characterized by the overproduction of platelets in the bone marrow, leading to an increased risk of blood clots and bleeding.
4. Primary Myelofibrosis (PMF): A disorder characterized by the replacement of normal bone marrow tissue with scar tissue, leading to impaired blood cell production and anemia, enlargement of the spleen, and increased risk of infections and bleeding.
5. Chronic Neutrophilic Leukemia (CNL): A rare disorder characterized by the overproduction of neutrophils (a type of white blood cell) in the bone marrow, leading to an increased number of these cells in the blood. CNL can lead to an increased risk of infections and organ damage.

MPDs are typically treated with a combination of therapies, including chemotherapy, targeted therapy, immunotherapy, and stem cell transplantation. The choice of treatment depends on several factors, including the subtype of MPD, the patient's age and overall health, and the presence of any comorbidities.

The spinal cord is a major part of the nervous system, extending from the brainstem and continuing down to the lower back. It is a slender, tubular bundle of nerve fibers (axons) and support cells (glial cells) that carries signals between the brain and the rest of the body. The spinal cord primarily serves as a conduit for motor information, which travels from the brain to the muscles, and sensory information, which travels from the body to the brain. It also contains neurons that can independently process and respond to information within the spinal cord without direct input from the brain.

The spinal cord is protected by the bony vertebral column (spine) and is divided into 31 segments: 8 cervical, 12 thoracic, 5 lumbar, 5 sacral, and 1 coccygeal. Each segment corresponds to a specific region of the body and gives rise to pairs of spinal nerves that exit through the intervertebral foramina at each level.

The spinal cord is responsible for several vital functions, including:

1. Reflexes: Simple reflex actions, such as the withdrawal reflex when touching a hot surface, are mediated by the spinal cord without involving the brain.
2. Muscle control: The spinal cord carries motor signals from the brain to the muscles, enabling voluntary movement and muscle tone regulation.
3. Sensory perception: The spinal cord transmits sensory information, such as touch, temperature, pain, and vibration, from the body to the brain for processing and awareness.
4. Autonomic functions: The sympathetic and parasympathetic divisions of the autonomic nervous system originate in the thoracolumbar and sacral regions of the spinal cord, respectively, controlling involuntary physiological responses like heart rate, blood pressure, digestion, and respiration.

Damage to the spinal cord can result in various degrees of paralysis or loss of sensation below the level of injury, depending on the severity and location of the damage.

The term "DNA, neoplasm" is not a standard medical term or concept. DNA refers to deoxyribonucleic acid, which is the genetic material present in the cells of living organisms. A neoplasm, on the other hand, is a tumor or growth of abnormal tissue that can be benign (non-cancerous) or malignant (cancerous).

In some contexts, "DNA, neoplasm" may refer to genetic alterations found in cancer cells. These genetic changes can include mutations, amplifications, deletions, or rearrangements of DNA sequences that contribute to the development and progression of cancer. Identifying these genetic abnormalities can help doctors diagnose and treat certain types of cancer more effectively.

However, it's important to note that "DNA, neoplasm" is not a term that would typically be used in medical reports or research papers without further clarification. If you have any specific questions about DNA changes in cancer cells or neoplasms, I would recommend consulting with a healthcare professional or conducting further research on the topic.

Lung neoplasms refer to abnormal growths or tumors in the lung tissue. These tumors can be benign (non-cancerous) or malignant (cancerous). Malignant lung neoplasms are further classified into two main types: small cell lung carcinoma and non-small cell lung carcinoma. Lung neoplasms can cause symptoms such as cough, chest pain, shortness of breath, and weight loss. They are often caused by smoking or exposure to secondhand smoke, but can also occur due to genetic factors, radiation exposure, and other environmental carcinogens. Early detection and treatment of lung neoplasms is crucial for improving outcomes and survival rates.

Parotid neoplasms refer to abnormal growths or tumors in the parotid gland, which is the largest of the salivary glands and is located in front of the ear and extends down the neck. These neoplasms can be benign (non-cancerous) or malignant (cancerous).

Benign parotid neoplasms are typically slow-growing, painless masses that may cause facial asymmetry or difficulty in chewing or swallowing if they become large enough to compress surrounding structures. The most common type of benign parotid tumor is a pleomorphic adenoma.

Malignant parotid neoplasms, on the other hand, are more aggressive and can invade nearby tissues and spread to other parts of the body. They may present as rapidly growing masses that are firm or fixed to surrounding structures. Common types of malignant parotid tumors include mucoepidermoid carcinoma, adenoid cystic carcinoma, and squamous cell carcinoma.

The diagnosis of parotid neoplasms typically involves a thorough clinical evaluation, imaging studies such as CT or MRI scans, and fine-needle aspiration biopsy (FNAB) to determine the nature of the tumor. Treatment options depend on the type, size, and location of the neoplasm but may include surgical excision, radiation therapy, and chemotherapy.

Cystadenoma is a type of benign tumor (not cancerous), which arises from glandular epithelial cells and is covered by a thin layer of connective tissue. These tumors can develop in various locations within the body, including the ovaries, pancreas, and other organs that contain glands.

There are two main types of cystadenomas: serous and mucinous. Serous cystadenomas are filled with a clear or watery fluid, while mucinous cystadenomas contain a thick, gelatinous material. Although they are generally not harmful, these tumors can grow quite large and cause discomfort or other symptoms due to their size or location. In some cases, cystadenomas may undergo malignant transformation and develop into cancerous tumors, known as cystadenocarcinomas. Regular medical follow-up and monitoring are essential for individuals diagnosed with cystadenomas to ensure early detection and treatment of any potential complications.

Neoplasms of connective and soft tissue are abnormal growths or tumors that develop in the body's supportive tissues, such as cartilage, tendons, ligaments, fascia, and fat. These neoplasms can be benign (non-cancerous) or malignant (cancerous).

Benign connective and soft tissue neoplasms include:
- Lipomas: slow-growing, fatty tumors that develop under the skin.
- Fibromas: firm, benign tumors that develop in connective tissue such as tendons or ligaments.
- Nevi (plural of nevus): benign growths made up of cells called melanocytes, which produce pigment.

Malignant connective and soft tissue neoplasms include:
- Sarcomas: a type of cancer that develops in the body's supportive tissues such as muscle, bone, fat, cartilage, or blood vessels. There are many different types of sarcomas, including liposarcoma (fatty tissue), rhabdomyosarcoma (muscle), and osteosarcoma (bone).
- Desmoid tumors: a rare type of benign tumor that can become aggressive and invade surrounding tissues. While not considered cancerous, desmoid tumors can cause significant morbidity due to their tendency to grow and infiltrate nearby structures.

Connective and soft tissue neoplasms can present with various symptoms depending on their location and size. Treatment options include surgery, radiation therapy, chemotherapy, or a combination of these modalities. Regular follow-up care is essential to monitor for recurrence or metastasis (spread) of the tumor.

Liver neoplasms refer to abnormal growths in the liver that can be benign or malignant. Benign liver neoplasms are non-cancerous tumors that do not spread to other parts of the body, while malignant liver neoplasms are cancerous tumors that can invade and destroy surrounding tissue and spread to other organs.

Liver neoplasms can be primary, meaning they originate in the liver, or secondary, meaning they have metastasized (spread) to the liver from another part of the body. Primary liver neoplasms can be further classified into different types based on their cell of origin and behavior, including hepatocellular carcinoma, cholangiocarcinoma, and hepatic hemangioma.

The diagnosis of liver neoplasms typically involves a combination of imaging studies, such as ultrasound, CT scan, or MRI, and biopsy to confirm the type and stage of the tumor. Treatment options depend on the type and extent of the neoplasm and may include surgery, radiation therapy, chemotherapy, or liver transplantation.

Plasma cell neoplasms are a type of cancer that originates from plasma cells, which are a type of white blood cell found in the bone marrow. These cells are responsible for producing antibodies to help fight off infections. When plasma cells become cancerous and multiply out of control, they can form a tumor called a plasmacytoma.

There are two main types of plasma cell neoplasms: solitary plasmacytoma and multiple myeloma. Solitary plasmacytoma is a localized tumor that typically forms in the bone, while multiple myeloma is a systemic disease that affects multiple bones and can cause a variety of symptoms such as bone pain, fatigue, and anemia.

Plasma cell neoplasms are diagnosed through a combination of tests, including blood tests, imaging studies, and bone marrow biopsy. Treatment options depend on the stage and extent of the disease, but may include radiation therapy, chemotherapy, and stem cell transplantation.

Appendiceal neoplasms refer to various types of tumors that can develop in the appendix, a small tube-like structure attached to the large intestine. These neoplasms can be benign or malignant and can include:

1. Adenomas: These are benign tumors that arise from the glandular cells lining the appendix. They are usually slow-growing and may not cause any symptoms.
2. Carcinoids: These are neuroendocrine tumors that arise from the hormone-producing cells in the appendix. They are typically small and slow-growing, but some can be aggressive and spread to other parts of the body.
3. Mucinous neoplasms: These are tumors that produce mucin, a slippery substance that can cause the appendix to become distended and filled with mucus. They can be low-grade (less aggressive) or high-grade (more aggressive) and may spread to other parts of the abdomen.
4. Adenocarcinomas: These are malignant tumors that arise from the glandular cells lining the appendix. They are relatively rare but can be aggressive and spread to other parts of the body.
5. Pseudomyxoma peritonei: This is a condition in which mucin produced by an appendiceal neoplasm leaks into the abdominal cavity, causing a jelly-like accumulation of fluid and tissue. It can be caused by both benign and malignant tumors.

Treatment for appendiceal neoplasms depends on the type and stage of the tumor, as well as the patient's overall health. Treatment options may include surgery, chemotherapy, or radiation therapy.

Vasculitis, Central Nervous System (CNS), refers to a group of disorders characterized by inflammation of blood vessels within the brain and/or spinal cord. This inflammation can cause damage to the blood vessel walls, leading to narrowing, blocking or weakening of the vessels, and in some cases, formation of aneurysms or rupture of the vessels.

The causes of CNS vasculitis are varied and can include infections, autoimmune diseases, medications, and unknown factors. The symptoms of CNS vasculitis depend on the severity and location of the inflammation, and may include headache, seizures, stroke-like symptoms (such as weakness or numbness in the face, arms, or legs), cognitive changes, and in severe cases, coma.

Diagnosis of CNS vasculitis typically involves a combination of clinical evaluation, imaging studies (such as MRI or angiography), and laboratory tests (including blood tests and analysis of cerebrospinal fluid). Treatment may involve corticosteroids, immunosuppressive medications, and/or other therapies aimed at reducing inflammation and preventing further damage to the blood vessels.

Lymphoma is a type of cancer that originates from the white blood cells called lymphocytes, which are part of the immune system. These cells are found in various parts of the body such as the lymph nodes, spleen, bone marrow, and other organs. Lymphoma can be classified into two main types: Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL).

HL is characterized by the presence of a specific type of abnormal lymphocyte called Reed-Sternberg cells, while NHL includes a diverse group of lymphomas that lack these cells. The symptoms of lymphoma may include swollen lymph nodes, fever, night sweats, weight loss, and fatigue.

The exact cause of lymphoma is not known, but it is believed to result from genetic mutations in the lymphocytes that lead to uncontrolled cell growth and division. Exposure to certain viruses, chemicals, and radiation may increase the risk of developing lymphoma. Treatment options for lymphoma depend on various factors such as the type and stage of the disease, age, and overall health of the patient. Common treatments include chemotherapy, radiation therapy, immunotherapy, and stem cell transplantation.

Nerve tissue proteins are specialized proteins found in the nervous system that provide structural and functional support to nerve cells, also known as neurons. These proteins include:

1. Neurofilaments: These are type IV intermediate filaments that provide structural support to neurons and help maintain their shape and size. They are composed of three subunits - NFL (light), NFM (medium), and NFH (heavy).

2. Neuronal Cytoskeletal Proteins: These include tubulins, actins, and spectrins that provide structural support to the neuronal cytoskeleton and help maintain its integrity.

3. Neurotransmitter Receptors: These are specialized proteins located on the postsynaptic membrane of neurons that bind neurotransmitters released by presynaptic neurons, triggering a response in the target cell.

4. Ion Channels: These are transmembrane proteins that regulate the flow of ions across the neuronal membrane and play a crucial role in generating and transmitting electrical signals in neurons.

5. Signaling Proteins: These include enzymes, receptors, and adaptor proteins that mediate intracellular signaling pathways involved in neuronal development, differentiation, survival, and death.

6. Adhesion Proteins: These are cell surface proteins that mediate cell-cell and cell-matrix interactions, playing a crucial role in the formation and maintenance of neural circuits.

7. Extracellular Matrix Proteins: These include proteoglycans, laminins, and collagens that provide structural support to nerve tissue and regulate neuronal migration, differentiation, and survival.

Endocrine gland neoplasms refer to abnormal growths (tumors) that develop in the endocrine glands. These glands are responsible for producing hormones, which are chemical messengers that regulate various functions and processes in the body. Neoplasms can be benign or malignant (cancerous). Benign neoplasms tend to grow slowly and do not spread to other parts of the body. Malignant neoplasms, on the other hand, can invade nearby tissues and organs and may also metastasize (spread) to distant sites.

Endocrine gland neoplasms can occur in any of the endocrine glands, including:

1. Pituitary gland: located at the base of the brain, it produces several hormones that regulate growth and development, as well as other bodily functions.
2. Thyroid gland: located in the neck, it produces thyroid hormones that regulate metabolism and calcium balance.
3. Parathyroid glands: located near the thyroid gland, they produce parathyroid hormone that regulates calcium levels in the blood.
4. Adrenal glands: located on top of each kidney, they produce hormones such as adrenaline, cortisol, and aldosterone that regulate stress response, metabolism, and blood pressure.
5. Pancreas: located behind the stomach, it produces insulin and glucagon, which regulate blood sugar levels, and digestive enzymes that help break down food.
6. Pineal gland: located in the brain, it produces melatonin, a hormone that regulates sleep-wake cycles.
7. Gonads (ovaries and testicles): located in the pelvis (ovaries) and scrotum (testicles), they produce sex hormones such as estrogen, progesterone, and testosterone that regulate reproductive function and secondary sexual characteristics.

Endocrine gland neoplasms can cause various symptoms depending on the type and location of the tumor. For example, a pituitary gland neoplasm may cause headaches, vision problems, or hormonal imbalances, while an adrenal gland neoplasm may cause high blood pressure, weight gain, or mood changes.

Diagnosis of endocrine gland neoplasms typically involves a combination of medical history, physical examination, imaging studies such as CT or MRI scans, and laboratory tests to measure hormone levels. Treatment options may include surgery, radiation therapy, chemotherapy, or hormonal therapy, depending on the type and stage of the tumor.

Eye neoplasms, also known as ocular tumors or eye cancer, refer to abnormal growths of tissue in the eye. These growths can be benign (non-cancerous) or malignant (cancerous). Eye neoplasms can develop in various parts of the eye, including the eyelid, conjunctiva, cornea, iris, ciliary body, choroid, retina, and optic nerve.

Benign eye neoplasms are typically slow-growing and do not spread to other parts of the body. They may cause symptoms such as vision changes, eye pain, or a noticeable mass in the eye. Treatment options for benign eye neoplasms include monitoring, surgical removal, or radiation therapy.

Malignant eye neoplasms, on the other hand, can grow and spread rapidly to other parts of the body. They may cause symptoms such as vision changes, eye pain, floaters, or flashes of light. Treatment options for malignant eye neoplasms depend on the type and stage of cancer but may include surgery, radiation therapy, chemotherapy, or a combination of these treatments.

It is important to note that early detection and treatment of eye neoplasms can improve outcomes and prevent complications. Regular eye exams with an ophthalmologist are recommended for early detection and prevention of eye diseases, including eye neoplasms.

Ovarian neoplasms refer to abnormal growths or tumors in the ovary, which can be benign (non-cancerous) or malignant (cancerous). These growths can originate from various cell types within the ovary, including epithelial cells, germ cells, and stromal cells. Ovarian neoplasms are often classified based on their cell type of origin, histological features, and potential for invasive or metastatic behavior.

Epithelial ovarian neoplasms are the most common type and can be further categorized into several subtypes, such as serous, mucinous, endometrioid, clear cell, and Brenner tumors. Some of these epithelial tumors have a higher risk of becoming malignant and spreading to other parts of the body.

Germ cell ovarian neoplasms arise from the cells that give rise to eggs (oocytes) and can include teratomas, dysgerminomas, yolk sac tumors, and embryonal carcinomas. Stromal ovarian neoplasms develop from the connective tissue cells supporting the ovary and can include granulosa cell tumors, thecomas, and fibromas.

It is essential to diagnose and treat ovarian neoplasms promptly, as some malignant forms can be aggressive and potentially life-threatening if not managed appropriately. Regular gynecological exams, imaging studies, and tumor marker tests are often used for early detection and monitoring of ovarian neoplasms. Treatment options may include surgery, chemotherapy, or radiation therapy, depending on the type, stage, and patient's overall health condition.

Neuroglia, also known as glial cells or simply glia, are non-neuronal cells that provide support and protection for neurons in the nervous system. They maintain homeostasis, form myelin sheaths around nerve fibers, and provide structural support. They also play a role in the immune response of the central nervous system. Some types of neuroglia include astrocytes, oligodendrocytes, microglia, and ependymal cells.

Mucinous cystadenoma is a type of benign tumor that arises from the epithelial cells lining the mucous membranes of the body. It is most commonly found in the ovary, but can also occur in other locations such as the pancreas or appendix.

Mucinous cystadenomas are characterized by the production of large amounts of mucin, a slippery, gel-like substance that accumulates inside the tumor and causes it to grow into a cystic mass. These tumors can vary in size, ranging from a few centimeters to over 20 centimeters in diameter.

While mucinous cystadenomas are generally benign, they have the potential to become cancerous (mucinous cystadenocarcinoma) if left untreated. Symptoms of mucinous cystadenoma may include abdominal pain or swelling, bloating, and changes in bowel movements or urinary habits. Treatment typically involves surgical removal of the tumor.

Experimental neoplasms refer to abnormal growths or tumors that are induced and studied in a controlled laboratory setting, typically in animals or cell cultures. These studies are conducted to understand the fundamental mechanisms of cancer development, progression, and potential treatment strategies. By manipulating various factors such as genetic mutations, environmental exposures, and pharmacological interventions, researchers can gain valuable insights into the complex processes underlying neoplasm formation and identify novel targets for cancer therapy. It is important to note that experimental neoplasms may not always accurately represent human cancers, and further research is needed to translate these findings into clinically relevant applications.

Meningeal neoplasms, also known as malignant meningitis or leptomeningeal carcinomatosis, refer to cancerous tumors that originate in the meninges, which are the membranes covering the brain and spinal cord. These tumors can arise primarily from the meningeal cells themselves, although they more commonly result from the spread (metastasis) of cancer cells from other parts of the body, such as breast, lung, or melanoma.

Meningeal neoplasms can cause a variety of symptoms, including headaches, nausea and vomiting, mental status changes, seizures, and focal neurological deficits. Diagnosis typically involves imaging studies (such as MRI) and analysis of cerebrospinal fluid obtained through a spinal tap. Treatment options may include radiation therapy, chemotherapy, or surgery, depending on the type and extent of the tumor. The prognosis for patients with meningeal neoplasms is generally poor, with a median survival time of several months to a year.

An axon is a long, slender extension of a neuron (a type of nerve cell) that conducts electrical impulses (nerve impulses) away from the cell body to target cells, such as other neurons or muscle cells. Axons can vary in length from a few micrometers to over a meter long and are typically surrounded by a myelin sheath, which helps to insulate and protect the axon and allows for faster transmission of nerve impulses.

Axons play a critical role in the functioning of the nervous system, as they provide the means by which neurons communicate with one another and with other cells in the body. Damage to axons can result in serious neurological problems, such as those seen in spinal cord injuries or neurodegenerative diseases like multiple sclerosis.

Central nervous system (CNS) agents are drugs or substances that act on the central nervous system, which includes the brain and spinal cord. These agents can affect the CNS in various ways, depending on their specific mechanism of action. They may be used for therapeutic purposes, such as to treat medical conditions like pain, anxiety, seizures, or sleep disorders, or they may be abused for their psychoactive effects.

CNS agents can be broadly classified into several categories based on their primary site of action and the nature of their effects. Some common categories of CNS agents include:

1. Depressants: These drugs slow down the activity of the CNS, leading to sedative, hypnotic, or anxiolytic effects. Examples include benzodiazepines, barbiturates, and sleep aids like zolpidem.
2. Stimulants: These drugs increase the activity of the CNS, leading to alertness, energy, and improved concentration. Examples include amphetamines, methylphenidate, and caffeine.
3. Analgesics: These drugs are used to treat pain and can act on various parts of the nervous system, including the peripheral nerves, spinal cord, and brain. Examples include opioids (such as morphine and oxycodone), non-opioid analgesics (such as acetaminophen and ibuprofen), and adjuvant analgesics (such as antidepressants and anticonvulsants).
4. Antiepileptics: These drugs are used to treat seizure disorders and work by modulating the electrical activity of neurons in the brain. Examples include phenytoin, carbamazepine, valproic acid, and lamotrigine.
5. Antipsychotics: These drugs are used to treat psychosis, schizophrenia, and other mental health disorders by blocking dopamine receptors in the brain. Examples include haloperidol, risperidone, and clozapine.
6. Antidepressants: These drugs are used to treat depression and anxiety disorders by modulating neurotransmitter activity in the brain. Examples include selective serotonin reuptake inhibitors (SSRIs) like fluoxetine and sertraline, tricyclic antidepressants like amitriptyline, and monoamine oxidase inhibitors (MAOIs) like phenelzine.
7. Anxiolytics: These drugs are used to treat anxiety disorders and work by modulating the activity of the neurotransmitter gamma-aminobutyric acid (GABA) in the brain. Examples include benzodiazepines like diazepam and alprazolam, and non-benzodiazepine anxiolytics like buspirone.
8. Stimulants: These drugs are used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy by increasing the activity of dopamine and norepinephrine in the brain. Examples include methylphenidate, amphetamine salts, and modafinil.
9. Sedative-hypnotics: These drugs are used to treat insomnia and other sleep disorders by depressing the activity of the central nervous system. Examples include benzodiazepines like triazolam and zolpidem, and non-benzodiazepine sedative-hypnotics like eszopiclone and ramelteon.
10. Antipsychotics: These drugs are used to treat psychotic disorders like schizophrenia, bipolar disorder, and major depressive disorder by blocking the activity of dopamine in the brain. Examples include typical antipsychotics like haloperidol and chlorpromazine, and atypical antipsychotics like risperidone and aripiprazole.
11. Antidepressants: These drugs are used to treat depression and anxiety disorders by increasing the activity of serotonin, norepinephrine, or dopamine in the brain. Examples include selective serotonin reuptake inhibitors (SSRIs) like fluoxetine and sertraline, tricyclic antidepressants like amitriptyline, and monoamine oxidase inhibitors (MAOIs) like phenelzine.
12. Anticonvulsants: These drugs are used to treat seizure disorders like epilepsy, as well as chronic pain and bipolar disorder. They work by stabilizing the electrical activity of the brain. Examples include valproic acid, lamotrigine, and carbamazepine.
13. Anxiolytics: These drugs are used to treat anxiety disorders by reducing anxiety and promoting relaxation. Examples include benzodiazepines like diazepam and alprazolam, and non-benzodiazepine anxiolytics like buspirone.
14. Hypnotics: These drugs are used to treat insomnia and other sleep disorders by promoting sleep. Examples include benzodiazepines like triazolam and temazepam, and non-benzodiazepine hypnotics like zolpidem and eszopiclone.
15. Stimulants: These drugs are used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy by increasing alertness and focus. Examples include amphetamine salts, methylphenidate, and modafinil.
16. Antihistamines: These drugs are used to treat allergies and allergic reactions by blocking the activity of histamine, a chemical that is released during an allergic response. Examples include diphenhydramine, loratadine, and cetirizine.
17. Antipsychotics: These drugs are used to treat psychosis, schizophrenia, bipolar disorder, and other mental health conditions by reducing the symptoms of these conditions. Examples include risperidone, olanzapine, and quetiapine.
18. Antidepressants: These drugs are used to treat depression, anxiety disorders, and some chronic pain conditions by increasing the levels of certain neurotransmitters in the brain. Examples include selective serotonin reuptake inhibitors (SSRIs) like fluoxetine and sertraline, and tricyclic antidepressants like amitriptyline and imipramine.
19. Anticonvulsants: These drugs are used to treat seizure disorders and some chronic pain conditions by stabilizing the electrical activity of the brain. Examples include valproic acid, lamotrigine, and carbamazepine.
20. Muscle relaxants: These drugs are used to treat muscle spasms and pain by reducing muscle tension. Examples include cyclobenzaprine, methocarbamol, and baclofen.

Gastrointestinal (GI) neoplasms refer to abnormal growths in the gastrointestinal tract, which can be benign or malignant. The gastrointestinal tract includes the mouth, esophagus, stomach, small intestine, large intestine, rectum, and anus.

Benign neoplasms are non-cancerous growths that do not invade nearby tissues or spread to other parts of the body. They can sometimes be removed completely and may not cause any further health problems.

Malignant neoplasms, on the other hand, are cancerous growths that can invade nearby tissues and organs and spread to other parts of the body through the bloodstream or lymphatic system. These types of neoplasms can be life-threatening if not diagnosed and treated promptly.

GI neoplasms can cause various symptoms, including abdominal pain, bloating, changes in bowel habits, nausea, vomiting, weight loss, and anemia. The specific symptoms may depend on the location and size of the neoplasm.

There are many types of GI neoplasms, including adenocarcinomas, gastrointestinal stromal tumors (GISTs), lymphomas, and neuroendocrine tumors. The diagnosis of GI neoplasms typically involves a combination of medical history, physical examination, imaging studies, and biopsy. Treatment options may include surgery, radiation therapy, chemotherapy, targeted therapy, or immunotherapy.

Pancreatic ductal carcinoma (PDC) is a specific type of cancer that forms in the ducts that carry digestive enzymes out of the pancreas. It's the most common form of exocrine pancreatic cancer, making up about 90% of all cases.

The symptoms of PDC are often vague and can include abdominal pain, jaundice (yellowing of the skin and eyes), unexplained weight loss, and changes in bowel movements. These symptoms can be similar to those caused by other less serious conditions, which can make diagnosis difficult.

Pancreatic ductal carcinoma is often aggressive and difficult to treat. The prognosis for PDC is generally poor, with a five-year survival rate of only about 9%. Treatment options may include surgery, chemotherapy, radiation therapy, or a combination of these approaches. However, because PDC is often not detected until it has advanced, treatment is frequently focused on palliative care to relieve symptoms and improve quality of life.

In situ hybridization (ISH) is a molecular biology technique used to detect and localize specific nucleic acid sequences, such as DNA or RNA, within cells or tissues. This technique involves the use of a labeled probe that is complementary to the target nucleic acid sequence. The probe can be labeled with various types of markers, including radioisotopes, fluorescent dyes, or enzymes.

During the ISH procedure, the labeled probe is hybridized to the target nucleic acid sequence in situ, meaning that the hybridization occurs within the intact cells or tissues. After washing away unbound probe, the location of the labeled probe can be visualized using various methods depending on the type of label used.

In situ hybridization has a wide range of applications in both research and diagnostic settings, including the detection of gene expression patterns, identification of viral infections, and diagnosis of genetic disorders.

Radiation-induced neoplasms are a type of cancer or tumor that develops as a result of exposure to ionizing radiation. Ionizing radiation is radiation with enough energy to remove tightly bound electrons from atoms or molecules, leading to the formation of ions. This type of radiation can damage DNA and other cellular structures, which can lead to mutations and uncontrolled cell growth, resulting in the development of a neoplasm.

Radiation-induced neoplasms can occur after exposure to high levels of ionizing radiation, such as that received during radiation therapy for cancer treatment or from nuclear accidents. The risk of developing a radiation-induced neoplasm depends on several factors, including the dose and duration of radiation exposure, the type of radiation, and the individual's genetic susceptibility to radiation-induced damage.

Radiation-induced neoplasms can take many years to develop after initial exposure to ionizing radiation, and they often occur at the site of previous radiation therapy. Common types of radiation-induced neoplasms include sarcomas, carcinomas, and thyroid cancer. It is important to note that while ionizing radiation can increase the risk of developing cancer, the overall risk is still relatively low, especially when compared to other well-established cancer risk factors such as smoking and exposure to certain chemicals.

A neoplasm of vascular tissue is an abnormal growth or mass of cells in the blood vessels or lymphatic vessels. These growths can be benign (non-cancerous) or malignant (cancerous). Benign neoplasms, such as hemangiomas and lymphangiomas, are typically not harmful and may not require treatment. However, they can cause symptoms if they grow large enough to press on nearby organs or tissues. Malignant neoplasms, such as angiosarcomas, are cancerous and can invade and destroy surrounding tissue, as well as spread (metastasize) to other parts of the body. Treatment for vascular tissue neoplasms depends on the type, size, location, and stage of the growth, and may include surgery, radiation therapy, chemotherapy, or a combination of these.

Spinal cord neoplasms refer to abnormal growths or tumors within the spinal cord. These can be benign (non-cancerous) or malignant (cancerous). They originate from the cells within the spinal cord itself (primary tumors), or they may spread to the spinal cord from other parts of the body (metastatic tumors). Spinal cord neoplasms can cause various symptoms depending on their location and size, including back pain, neurological deficits, and even paralysis. Treatment options include surgery, radiation therapy, and chemotherapy.

Nervous system trauma, also known as neurotrauma, refers to damage or injury to the nervous system, including the brain and spinal cord. This type of trauma can result from various causes, such as vehicular accidents, sports injuries, falls, violence, or penetrating traumas. Nervous system trauma can lead to temporary or permanent impairments in sensory, motor, or cognitive functions, depending on the severity and location of the injury.

Traumatic brain injury (TBI) is a common form of nervous system trauma that occurs when an external force causes brain dysfunction. TBIs can be classified as mild, moderate, or severe, based on factors such as loss of consciousness, memory loss, and neurological deficits. Mild TBIs, also known as concussions, may not cause long-term damage but still require medical attention to ensure proper healing and prevent further complications.

Spinal cord injuries (SCI) are another form of nervous system trauma that can have severe consequences. SCI occurs when the spinal cord is damaged due to a sudden, traumatic blow or cut, causing loss of motor function, sensation, or autonomic function below the level of injury. The severity and location of the injury determine the extent of impairment, which can range from partial to complete paralysis.

Immediate medical intervention is crucial in cases of nervous system trauma to minimize secondary damage, prevent complications, and optimize recovery outcomes. Treatment options may include surgery, medication, rehabilitation, or a combination of these approaches.

Molecular sequence data refers to the specific arrangement of molecules, most commonly nucleotides in DNA or RNA, or amino acids in proteins, that make up a biological macromolecule. This data is generated through laboratory techniques such as sequencing, and provides information about the exact order of the constituent molecules. This data is crucial in various fields of biology, including genetics, evolution, and molecular biology, allowing for comparisons between different organisms, identification of genetic variations, and studies of gene function and regulation.

Nose neoplasms refer to abnormal growths or tumors in the nasal cavity or paranasal sinuses. These growths can be benign (non-cancerous) or malignant (cancerous). Benign neoplasms are typically slow-growing and do not spread to other parts of the body, while malignant neoplasms can invade surrounding tissues and have the potential to metastasize.

Nose neoplasms can cause various symptoms such as nasal congestion, nosebleeds, difficulty breathing through the nose, loss of smell, facial pain or numbness, and visual changes if they affect the eye. The diagnosis of nose neoplasms usually involves a combination of physical examination, imaging studies (such as CT or MRI scans), and biopsy to determine the type and extent of the growth. Treatment options depend on the type, size, location, and stage of the neoplasm and may include surgery, radiation therapy, chemotherapy, or a combination of these approaches.

A nervous system neoplasm is a tumor affecting the nervous system. Types include: Nerve sheath tumor Brain tumor Arachnoid cyst ... Nervous system neoplasia, All stub articles, Nervous system disease stubs, Neoplasm stubs). ... "neoplasm of the central nervous system (Concept Id: C0085136) - MedGen - NCBI". www.ncbi.nlm.nih.gov. Retrieved 23 July 2021. v ...
Percy AK, Elveback LR, Okazaki H, Kurland LT (January 1972). "Neoplasms of the central nervous system. Epidemiologic ... 1-19, ISBN 9780470753064 Kintomo T (1982). Metastatic tumors of the central nervous system. Igaku-Shoin. ISBN 978-0896400672. ... Neoplasm Metastasis Cancer Brain tumor Garsa A, Jang JK, Baxi S, Chen C, Akinniranye O, Hall O, Larkin J, Motala A, Hempel S ( ... in the Metropolitan Detroit Cancer Surveillance System". Journal of Clinical Oncology. 22 (14): 2865-72. doi:10.1200/jco. ...
"A systematic review of inhaled intranasal therapy for central nervous system neoplasms: an emerging therapeutic option". ... The new 2016 WHO Classification of Tumors of the Central Nervous System was a paradigm shift: some of the tumors were defined ... However, metastasis of GBM beyond the central nervous system is extremely unusual. About 50% of GBMs occupy more than one lobe ... It is the second-most common central nervous system tumor after meningioma. It occurs more commonly in males than females. ...
... Nervous system neoplasm List of brain tumor cases "Adult Brain Tumors Treatment". NCI. 28 February 2014. Archived ... The spinal cord is considered a part of the central nervous system. It is made up of the same cells as the brain: neurons and ... Central nervous system tumors make up 20-25 percent of cancers in children. The average survival rate for all primary brain ... "Cancer of the Brain and Other Nervous System - Cancer Stat Facts". SEER. Retrieved 22 July 2019. Vos T, Allen C, Arora M, ...
... infections affecting the central nervous system, neurodegenerative disease, and neoplasms. A cerebrovascular event is more ...
Even if, by general rule, neoplasms of the nervous system (brain tumors) cannot metastasize into the body because of the blood- ... "Adult Central Nervous System Tumors Treatment". National Cancer Institute. 26 August 2016. Archived from the original on 28 ... Nervous system neoplasia, Wikipedia medicine articles ready to translate). ... The neoplasms currently referred to as meningiomata were referred to with a wide range of names in older medical literature, ...
... neoplasms of the central nervous system, emotional and behavior disorders, and intellectual disability. The current reference ... Lead affects the peripheral nervous system (especially motor nerves) and the central nervous system. Peripheral nervous system ... Lead affects every one of the body's organ systems, especially the nervous system, but also the bones and teeth, the kidneys, ... Effects of lead on the physiology of the kidneys and blood are generally reversible; its effects on the central nervous system ...
A nerve sheath tumor is a type of tumor of the nervous system (nervous system neoplasm) which is made up primarily of the ... Nervous system neoplasia, All stub articles, Neoplasm stubs). ... WHO Classification of Tumours of the Central Nervous System. ... A peripheral nerve sheath tumor (PNST) is a nerve sheath tumor in the peripheral nervous system. Benign peripheral nerve sheath ... PubMed: 11438454] Chaubal A, Paetau A, Zoltick P, Miettinen M. CD34 immunoreactivity in nervous system tumors. Acta Neuropathol ...
... s (NETs) are neoplasms that arise from cells of the endocrine (hormonal) and nervous systems. They most ... Currently there is no one staging system for all neuroendocrine neoplasms. Well-differentiated lesions generally have their own ... G1 and G2 neuroendocrine neoplasms are called neuroendocrine tumors (NETs) - formerly called carcinoid tumours. G3 neoplasms ... Nervous system neoplasia, Endocrine neoplasia, Pancreatic cancer, Infectious causes of cancer, Neuroendocrinology). ...
Syndromes affecting the nervous system, Hematologic neoplasms). ... Even so, due to the lack of regeneration of the nervous system ... There's no clear definition of BNS but what is known so far is that unlike WM, It involves the central nervous system (CNS), ... This is to limit the amount of radiation and prevent further damage to the nervous system, which could happen due to the ... MRI with gadolinium contrast is the primary radiologic tool used to diagnose ailments of the central nervous system, BNS ...
Nervous system neoplasia, Melanocytic nevi and neoplasms). ...
Nervous system disease stubs, Neoplasm stubs). ... Neurocytoma is a type of nervous system benign tumor which is ... primarily derived from nervous tissue. Central neurocytoma "neurocytoma" at Dorland's Medical Dictionary v t e v t e (Articles ...
Brain Neoplasm, Central Nervous System Neoplasm, High Grade Glioma: Gliosarcoma, Medulloblastomas, Oligodendroglioma, Acute T ... Cell Leukemia Lymphoma, Bone Cancer, Breast Neoplasms, Colorectal Neoplasms, Lung Neoplasms, Malignancies Multiple, Metastatic ...
Neoplasms benign, malignant and unspecified (incl cysts and polyps); Nervous system disorders; Pregnancy, puerperium and ... The 27 System Organ Classes (SOCs) represent parallel axes that are not mutually exclusive. This characteristic, called "multi- ... The highest or broadest level is System Organ Class (SOC), further divided into High-Level Group Terms (HLGT), High-Level Terms ... As of MedDRA 25.1 (September 2022): SOC - 27 The 27 SOCs are: Blood and lymphatic system disorders; Cardiac disorders; ...
... s are uncommon tumors of the central nervous system that account for 0.5-0.6% of intracranial neoplasms in ... The 2007 WHO classification of tumours of the central nervous system, Acta Neuropathol. 114 (2) (2007) 97-109. I. Nakano, A. ... The 2016 world health organization classification of tumours of the central nervous system: what the paediatric ... Pediatric choroid plexus neoplasms: MR, CT, and pathologic correlation, Radiology 173 (1) (1989) 81-88 A.W. McEvoy, B.N. ...
Malignant neoplasms of the brain and nervous system (1.5%) Retinal detachment (1.4%) Cataracts are the greying or opacity of ... For example, the Canadian currency tactile feature is a system of raised dots in one corner, based on braille cells but not ... The American Medical Association has estimated that the loss of one eye equals 25% impairment of the visual system and 24% ... Primarily, this is by use of magnification in the form of telescopic systems for distance vision and optical or electronic ...
They are most commonly tumors in the central or peripheral nervous system.[citation needed] Tumors exhibiting neuroectodermal ... A neuroectodermal neoplasm is a neoplasm or tumor of the neuroectoderm. ... They include pituitary adenoma and carcinoid tumor Group II tumors/neoplasms: nonepithelial neuroectodermal neoplasms. These ... Nervous system neoplasia, All stub articles, Oncology stubs). ... "Neuroectodermal Neoplasms of the Head and Neck with Emphasis on ...
"Newly codified glial neoplasms of the 2007 WHO Classification of Tumours of the Central Nervous System: angiocentric glioma, ... Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (2016). WHO classification of tumours of the central nervous system (Revised 4th ed ... In 2007, the Fourth Edition of the World Health Organization Classification of Tumors of the Central Nervous System recognized ... June 2016). "The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary". Acta ...
They look like intracranial neoplasms, and sometimes they get biopsied as suspected tumors. Proton MR spectroscopy can help in ... However, in a person with MS, these cells recognize healthy parts of the central nervous system as foreign and attack them as ... Multiple sclerosis and other demyelinating diseases of the central nervous system (CNS) produce lesions (demyelinated areas in ... "Demyelinating diseases of the central nervous system". Medicine. 11 (77): 4601-4609. doi:10.1016/j.med.2015.04.001. Poser C. M ...
... neoplasms, and cysts, Syndromes affecting the nervous system). ... The most common structural central nervous system abnormalities ... associated with anomalies of the central nervous system, ocular system, skeletal system, cardiovascular system and ... urinary system issues include horseshoe kidney and duplicated urinary collection system. Schimmelpenning syndrome appears to be ... Depending on the systems involved, an individual with Schimmelpenning syndrome may need to see an interdisciplinary team of ...
The neurofibroma is a benign nerve-sheath tumor in the peripheral nervous system. It appears in the sex cord-stromal tumour ... group of ovarian neoplasms. Ovary fibromas are most frequent during middle age, and rare in children. Upon gross pathological ...
Melanocytic nevi and neoplasms, Syndromes affecting head size, Syndromes affecting the nervous system, Syndromes affecting the ... Thyroid Breast Renal List of cutaneous conditions List of cutaneous neoplasms associated with systemic syndromes Disorders, the ...
Benign neoplasms). ... Clinical symptoms of central nervous system origin include ... Cerebral cavernous malformation (CCM) is a cavernous hemangioma that arises in the central nervous system. It can be considered ... Since CCMs are low flow lesions (they are hooked into the venous side of the circulatory system), they will be angiographically ...
Childs Nervous System, 24, 379-384. M. Kern, P. R., G. Lee, P. Watson. (2006). Papillary tumor of the pineal region- a new ... The critical diagnosis of this neoplasm is often difficult because of its similarity with other primary or secondary papillary ... Papillary tumors of the central nervous system and particularly of the pineal region are very rare and so diagnosing them is ... WHO classification of tumours of the central nervous system, chapter 7, Eds: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, IARC ...
... are neuroendocrine neoplasms that arise from cells of the endocrine (hormonal) and nervous system within the pancreas. PanNETs ... A different TNM system for PanNETs has been proposed by The European Neuroendocrine Tumor Society. Pancreatic neuroendocrine ... The NCCN recommends the use of the same AJCC-UICC staging system as pancreatic adenocarcinoma.: 52 Using this scheme, the stage ... Only 1 or 2% of clinically significant pancreas neoplasms are PanNETs. The majority of PanNETs are benign, while some are ...
... urinary organs 224 Benign neoplasm of eye 225 Benign neoplasm of brain and other parts of nervous system 226 Benign neoplasm of ... neoplasm of eye 191 Malignant neoplasm of brain 192 Malignant neoplasm of other and unspecified parts of nervous system 192.0 ... 140 Malignant neoplasm of lip 141 Malignant neoplasm of tongue 142 Malignant neoplasm of major salivary glands 143 Malignant ... neoplasm of lymph nodes 197 Secondary malignant neoplasm of respiratory and digestive systems 198 Secondary malignant neoplasm ...
... central nervous system, or other tissues. The neoplasm occurs in individuals of all ages but predominates in the elderly; in ... Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy. It was initially regarded as a form of ... Blastic plasmacytoid dendritic cell neoplasm is an aggressive malignancy with features of cutaneous lymphoma (e.g. malignant ... Blastic plasmacytoid dendritic cell neoplasm occurs in children, including neonates, but is more common in adults, particularly ...
Nervous system disease stubs, Dermal and subcutaneous growth stubs, Epidermal nevi, neoplasm, cyst stubs). ... v t e v t e v t e (Articles with short description, Short description is different from Wikidata, Epidermal nevi, neoplasms, ...
... neoplasms 8.1.1 Meningeal melanocytosis and meningeal melanomatosis 8.2 Circumscribed meningeal melanocytic neoplasms 8.2.1 ... Grading of the tumors of the central nervous system See the article Grading of the tumors of the central nervous system. Louis ... Pathology and genetics of tumours of the nervous system. IARC Press This is the classification that began to suggest the use ... The following is a simplified (deprecated) version of the 2021 WHO classification of the tumours of the central nervous system ...
... cranial nerves and other parts of central nervous system ICD-10 code Siemens C72, a mobile phone Honda C71, C76, C72, C77 Dream ... C72 may refer to : Ruy Lopez chess openings ECO code Malignant neoplasm of spinal cord, ...
A nervous system neoplasm is a tumor affecting the nervous system. Types include: Nerve sheath tumor Brain tumor Arachnoid cyst ... Nervous system neoplasia, All stub articles, Nervous system disease stubs, Neoplasm stubs). ... "neoplasm of the central nervous system (Concept Id: C0085136) - MedGen - NCBI". www.ncbi.nlm.nih.gov. Retrieved 23 July 2021. v ...
Information about the SNOMED CT code 372062007 representing Malignant neoplasm of central nervous system. ... Neoplasm of nervous system 126950007. Malignant neoplasm of nervous system 372063002. Malignant neoplasm of central nervous ... Central nervous system finding 246556002. Disorder of the central nervous system 23853001. Neoplasm of central nervous system ... Central nervous system finding 246556002. Disorder of the central nervous system 23853001. Neoplasm of central nervous system ...
Blastic plasmacytoid dendritic cell neoplasm frequently shows occult central nervous system involvement at diagnosis and ... is a rare aggressive myeloid neoplasm which shows a high rate of central nervous system (CNS) recurrence and overall survival ( ...
... primary central nervous system melanocytic neoplasms. uveal melanoma; primary central nervous system melanocytic neoplasms. ...
Abnormality of the nervous system*Abnormal nervous system morphology*Neoplasm of the nervous system*Cranial nerve neoplasm* ... Nervous system benign neoplasm*Benign Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm*Central nervous system ... Malignant neoplasm of nervous system*Malignant neoplasm of the central nervous system*Anaplastic ganglioglioma ... Neoplasm of the central nervous system*Adult Central Nervous System Neoplasm*Adult astrocytic tumor ...
A primary central nervous system neoplasm that is resistant to treatment. ... Neoplasm of the central nervous system*Primary Central Nervous System Neoplasm*Refractory Primary Central Nervous System ... Refractory Primary Central Nervous System Neoplasm Refractory Primary Central Nervous System Neoplasm. ... Disorder of nervous system*Disorder of the central nervous system* ...
Malignant neoplasms of the peripheral nerves and autonomic nervous system; and other connective and soft tissue. ... Malignant neoplasm of the urinary bladder.. * Malignant neoplasm of the kidney.. * Malignant neoplasms of the renal pelvis; ... Malignant neoplasm of the thyroid.. * Malignant neoplasms of the blood and lymphoid tissues (including, but not limited to, ... Malignant neoplasms of the liver and intrahepatic bile duct.. * Malignant neoplasms of the retroperitoneum and peritoneum; ...
... classification of nervous system tumors, published in 2000, emerged from a 1999 international consensus conference of ... Nervous System Neoplasms / classification* * Nervous System Neoplasms / pathology * Nervous System Neoplasms / therapy ... The WHO classification of tumors of the nervous system J Neuropathol Exp Neurol. 2002 Mar;61(3):215-25; discussion 226-9. doi: ... The 2000 WHO classification of nervous system tumors aims at being used and implemented by the neuro-oncology and biomedical ...
... it is the most lethal form of skin cancer and the third most common malignancy that causes central nervous system (CNS) ... Primary melanocytic neoplasms of the central nervous systems. Am J Surg Pathol. 1999 Jul. 23(7):745-54. [QxMD MEDLINE Link]. ... The following conditions are considered in the differential diagnosis of central nervous system (CNS) melanoma:. * Brainstem ... Central nervous system (CNS) metastases are characterized by solitary or multiple brain lesions of different sizes and ...
... central nervous system neoplasms. We are interested in exploiting genetic changes for both diagnostic and therapeutic purposes ... We have shown that each colon neoplasm arises from a clonal expansion of one transformed cell. This expansion gives rise to a ... Copyright © The Johns Hopkins University, The Johns Hopkins Hospital, and The Johns Hopkins Health System Corporation. All ...
Cimino, P. J., & Perrin, R. J. (2014). Mammaglobin-a immunohistochemistry in primary central nervous system neoplasms and ... Cimino, Patrick J. ; Perrin, Richard J. / Mammaglobin-a immunohistochemistry in primary central nervous system neoplasms and ... Cimino, PJ & Perrin, RJ 2014, Mammaglobin-a immunohistochemistry in primary central nervous system neoplasms and intracranial ... Mammaglobin-a immunohistochemistry in primary central nervous system neoplasms and intracranial metastatic breast carcinoma. ...
RET-protooncogene variants in patients with sporadic neoplasms of the digestive tract and the central nervous system.在哪里下载?这篇文献 ... RET-protooncogene variants in patients with sporadic neoplasms of the digestive tract and the central nervous system.. Abstract ... RET-protooncogene variants in patients with sporadic neoplasms of the digestive tract and the central nervous system. ... Next-generation narrow band imaging system for colonic polyp detection: a prospective multicenter randomized trial. abstract: ...
Purpose: To compare ascertainment of central nervous system (CNS) neoplasms with the use of mortality and incidence data as ... Central Nervous System Neoplasms; Death Certificates; Methodology; Mortality ... Cancer; Cancer-rates; Central-nervous-system-disorders; Epidemiology; Statistical-analysis; Aircraft-engines; Aircraft-parts- ... A comparison of central nervous system cancer ascertainment using mortality and incidence data. ...
Nervous System Neoplasms (1) * Blood Cancers (1) * Breast Neoplasms (1) * Endocrine System Neoplasms (1) ...
Categories: Nervous System Neoplasms Image Types: Photo, Illustrations, Video, Color, Black&White, PublicDomain, ...
Nervous System Neoplasms. *Central Nervous System Neoplasms. .map{width:100%;height:300px;margin-bottom:15px;} Name. Location. ...
Nervous System Neoplasms. *Central Nervous System Neoplasms. .map{width:100%;height:300px;margin-bottom:15px;} Name. Location. ...
Yachnis AT, Perry A. Embryonal neoplasms of the central nervous system. In: Perry A, Brat DJ, eds. Practical Surgical ... The central nervous system (CNS) origins of medulloblastoma can be confirmed by immunohistochemical studies. Synaptophysin, ... Medulloblastoma is the most common malignant central nervous system (CNS) tumor of childhood, with an annual incidence of about ... WHO Classification of Tumours of the Central Nervous System. Lyon, France: International Agency for Research on Cancer (IARC); ...
Alvord, Jr., E. C. & Shaw, C. M. Neoplasms affecting the nervous system of the elderly (Oxford University Press, 1991). ... For the system of Equations (9 and 10), we have two straight lines in the phase plane where dU/dz is infinite, at C = α and C ... To generate phase planes we substitute U = dC/dz into the second order travelling wave ODE to obtain a system of two first- ... a,d) Phase plane for the system (24 and 25) with the numerical solution of Equation (21) (cyan, solid), in (C, U) co-ordinates ...
Information about the SNOMED CT code 94767002 representing Neoplasm of uncertain behavior of brain. ... Central nervous system finding 246556002. Disorder of the central nervous system 23853001. Neoplasm of central nervous system ... Neoplasm of uncertain behavior of central nervous system 94784008. Neoplasm of uncertain behavior of brain and spinal cord ... Neoplasm of head 126631009. Neoplasm of uncertain behavior of head 94864000. Neoplasm of uncertain behavior of brain 94767002. ...
Nervous System Neoplasms, Leukemia, Melanoma, Epidemiology, Sarcoma, Lung Neoplasms, Breast Neoplasms, Medical Oncology, ... Central Nervous System Neoplasms, Neuroblastoma, Sarcoma, Bone Neoplasms, Wilms Tumor, Medical Oncology, Pediatrics ...
Central Nervous System Neoplasms. 31. Degenerative Diseases of the Central Nervous System ... These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in ... Presents key information in at-a-glance format that is organized by body system for easy reference ... EXPANDED chapter on the lymphatic system features additional sections on lymphatic diseases plus exercise guidelines, education ...
Benign Neoplasm. Brain Cancer. Brain Tumor. Cavernous Malformation. Central Nervous System Neoplasm ... Due to the different physician groups and hospitals within the Wake Forest Baptist system, physician services and hospital ...
Women with a history of benign neoplasm of meninges, benign neoplasm of brain and other parts of the central nervous system, or ... New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer ... Familial risks in nervous-system tumours: a histology-specific analysis from Sweden and Norway. Lancet Oncol2009;10:481-8. doi: ... Tumors of the nervous system and pituitary gland associated with atomic bomb radiation exposure. J Natl Cancer Inst2002;94:1555 ...
Yachnis AT, Perry A. Embryonal neoplasms of the central nervous system. In: Perry A, Brat DJ, eds. Practical Surgical ... The central nervous system (CNS) origins of medulloblastoma can be confirmed by immunohistochemical studies. Synaptophysin, ... Medulloblastoma is the most common malignant central nervous system (CNS) tumor of childhood, with an annual incidence of about ... WHO Classification of Tumours of the Central Nervous System. Lyon, France: International Agency for Research on Cancer (IARC); ...
... of which the Idylla system seems to be a promising tool. ... is an important oncological target in certain central nervous ... system (CNS) tumors, for which a possible application of BRAF-targeted therapy grows continuously. In the present study, we aim ... F. Behling, A. Barrantes-Freer, M. Skardelly et al., "Frequency of BRAF V600E mutations in 969 central nervous system neoplasms ... "Factors affecting diagnosis of primary pediatric central nervous system neoplasias in a developing country," Childs Nervous ...
Keywords : adolescent, adult, Central Nervous System Cysts, Cerebral Ventricle Neoplasms, endoscopy, female, Humans, ... Tamil Nadu offers various engineering programs developed on a choice-based credit system following continuous evaluation by ...
Meningiomas are the most common neoplasm of the central nervous system. Usually benign and generally discovered incidentally at ... More efficient vaporization by the 200-W Thulium laser system than by the GreenLight high-performance system (HPS) 120-W system ... The Japanese healthcare system is characterized by universal coverage and free access. It is an excellent social system that ... and the GreenLight high-performance system (HPS) 120-W system for benign prostatic hyperplasia (BPH). Methods: Between February ...
Neoplasm of the central nervous system Unsteady gait Vomiting Abnormal sacrum morphology Neoplasm of the skin Abnormality of ... Body Systems. Symptoms related to this disease may affect different systems of the body. Use the Filter and Sort function to ... 2023). Unified Medical Language System (UMLS).. *National Academies of Sciences, Engineering, and Medicine. (2015). Improving ... Neoplasm of The Central Nervous System. Synonym: Neoplasm of The Cns. Synonym: Tumors of The Central Nervous System ...
  • Glioblastoma (GBM) is a malignant central nervous system neoplasm that remains largely incurable. (jnccn.org)
  • The new World Health Organization (WHO) classification of nervous system tumors, published in 2000, emerged from a 1999 international consensus conference of neuropathologists. (nih.gov)
  • The 2000 WHO classification of nervous system tumors aims at being used and implemented by the neuro-oncology and biomedical research communities worldwide. (nih.gov)
  • The BRAF V600E mutation is an important oncological target in certain central nervous system (CNS) tumors, for which a possible application of BRAF-targeted therapy grows continuously. (hindawi.com)
  • Brain tumors are a diverse group of neoplasms arising from different cells within the CNS or from primary tumors of other organs that spread to the CNS. (hindawi.com)
  • Gliomas, the deadliest form of primary central nervous system neoplasms, represent about 70 percent of brain tumors, according to Sareddy. (medindia.net)
  • Gastric schwannoma represent only 0.2% of all gastric tumors and 4% of all benign gastric neoplasms. (sages.org)
  • Glioblastoma, previously known as glioblastoma multiforme, is the most aggressive among infiltrative gliomas, a group of primary tumors arising from the central nervous system (CNS). (cancernetwork.com)
  • 1] 'Multiforme,' which refers to a heterogenous histologic appearance and proliferation of multiple cell types, was abandoned from the revised nomenclature in the 2007 World Health Organization Classification of Tumors of the Central Nervous System, and is now simply called 'glioblastoma. (cancernetwork.com)
  • A primary central nervous system neoplasm that is resistant to treatment. (nih.gov)
  • How I prevent and treat central nervous system disease in adults with acute lymphoblastic leukemia. (nih.gov)
  • Central nervous system involvement in childhood acute lymphoblastic leukemia: challenges and solutions. (nih.gov)
  • In neurosurgical cases with ambiguous cellular morphology and/or limited biopsy material, immunohistochemistry (IHC) is often performed to distinguish metastases from primary central nervous system (CNS) neoplasms. (wustl.edu)
  • it is the most lethal form of skin cancer and the third most common malignancy that causes central nervous system (CNS) metastases, after lung and breast cancer. (medscape.com)
  • Metastases reach the central nervous system (CNS) via hematogenous spread of tumor cells. (medscape.com)
  • A comparison of central nervous system cancer ascertainment using mortality and incidence data. (cdc.gov)
  • Purpose: To compare ascertainment of central nervous system (CNS) neoplasms with the use of mortality and incidence data as part of an occupational epidemiology study. (cdc.gov)
  • Medulloblastoma is the most common malignant central nervous system (CNS) tumor of childhood, with an annual incidence of about 0.5-0.8/100,000 in children younger than 19 years. (medscape.com)
  • Gastrointestinal schwannomas are rare benign neoplasms that are distinctively unique when compared to soft-tissue and central nervous system mesenchymal neoplasms. (sages.org)
  • Glioblastoma is an aggressive primary tumor of the central nervous system. (cancernetwork.com)
  • Importance: Cerebrospinal fluid (CSF) cytologic testing and flow cytometry are insensitive for diagnosing neoplasms of the central nervous system (CNS). (stanford.edu)
  • Work in Dr. Michael Sofroniew's laboratory is directed at understanding glial cell responses to injury, degenerative disease or neoplasm in the adult central nervous system (CNS). (uclahealth.org)
  • Finally, we discuss the possible future role of these white matter maps in the assessment of white matter diseases, congenital brain malformations, central nervous system neoplasms (presurgical evaluation), and brain function. (ajronline.org)
  • Anatomic detail can be acquired with conventional structural imaging, but newer approaches also add capabilities to interrogate image-derived physiologic and molecular characteristics of central nervous system neoplasms. (minervamedica.it)
  • Neoplasms of the central nervous system could be divided into primary and metastatic tumours, each accounting for approximating half of all brain tumours. (hku.hk)
  • A nervous system neoplasm is a tumor affecting the nervous system. (wikipedia.org)
  • A tumor (abnormal growth of tissue) of the nervous system. (beds.ac.uk)
  • These findings suggest that MGA IHC staining intensity and distribution can distinguish metastases from primary CNS neoplasms (P=0.0086) in women with a history of breast carcinoma but also indicate that cytologic staining patterns must be interpreted for more accurate tumor classification. (wustl.edu)
  • Our study found that BRAF V600E mutations are moderately frequent in PA and GG and that for these tumor entities, IHC VE1 is suitable for screening purposes, but all negative, equivocal, and weak positive cases should be further tested with molecular biology techniques, of which the Idylla system seems to be a promising tool. (hindawi.com)
  • Experience in the SEER registries has shown that using the Supplemental List increases casefinding for benign brain and CNS, hematopoietic neoplasms, and other reportable diseases. (cancer.gov)
  • 11%, endocrine disorders 2.5 times (including diabetes 3.7 times), nervous system diseases 15%, malignant neoplasms 30% have increased. (who.int)
  • NCDs accounted for 50% of al diseases, including 17.6% circulatory system diseases, 15% respiratory system diseases, 15% endocrine disorders, 2.7% malignant neoplasms. (who.int)
  • We obtained the underlying causes of death from the regional mortality register and grouped them into 5 categories according to the International Classification of Diseases, 10th Revision: neoplasms (codes C00-D49), nervous system diseases (codes G00-G99), circulatory system diseases (codes I00-I99), respiratory system diseases (codes J00-J99), and all other causes. (cdc.gov)
  • The test performance study used 125 residual laboratory CSF specimens from 47 patients with a CNS malignant neoplasm and 56 patients with other neurological diseases. (stanford.edu)
  • Here, we describe the frequency and patterns of IHC reactivity for MGA in metastatic and primary CNS neoplasms from patients with well-documented histories of breast carcinoma. (wustl.edu)
  • anaplastic carcinoma of the mammary gland has an epithelial origin and is considered the most malignant neoplasm with worst prognosis due to its characteristic of high cellular pleomorphism and the ability of invasiveness of vessels and adjacent tissues. (ufrgs.br)
  • The ICD-10 code range for Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes D37-D48 is medical classification list by the World Health Organization (WHO). (aapc.com)
  • The term 'glioblastoma multiforme' was introduced in the 1926 classification system devised by Cushing and Bailey. (cancernetwork.com)
  • the reactivity of MGA in primary and metastatic CNS neoplasms has never been described. (wustl.edu)
  • The outcome after surgery is excellent as these neoplasms are generally benign in nature. (sages.org)
  • Symptoms related to this disease may affect different systems of the body. (nih.gov)
  • Use the 'Filter and Sort' function to learn more about which body system(s) are affected by this disease and their associated symptom(s). (nih.gov)
  • The second study evaluated patients who were enrolled in an ongoing prospective study between April 1, 2014, and July 31, 2019, with presentations that were suggestive of neuroinflammatory disease but who were ultimately diagnosed with a CNS malignant neoplasm. (stanford.edu)
  • The incidence of melanoma is increasing faster than that of any other malignant neoplasm, except for lung cancer in women. (medscape.com)
  • Metastases represent the most common type of intracranial neoplasm. (wustl.edu)
  • Importantly, the cytoarchitectural staining characteristics among all 4 MGA-positive primary CNS neoplasms (cytoplasmic and nuclear) differed from those of the metastases (cytoplasmic and membranous). (wustl.edu)
  • Resection (all patients): Patients undergo maximal resection (en bloc, if feasible) followed by placement of 2-3 peritumoral catheters (4 days after completion of pre-resection infusion for the initial cohorts of patients and at study entry for subsequent cohorts of patients). (knowcancer.com)
  • Stereotaxic space, a coordinate system applied across scan data to relate data from different patients and different time points in a common 3D space, has been used to advance segmentation techniques. (ajnr.org)
  • The first study used CSF specimens collected at the UCSF Clinical Laboratories between July 1, 2017, and December 31, 2019, and evaluated test performance in specimens from patients with a CNS malignant neoplasm (positive controls) or without (negative controls). (stanford.edu)
  • Benign and malignant neoplastic processes arising from or involving components of the central, peripheral, and autonomic nervous systems, cranial nerves, and meninges. (uchicago.edu)
  • Medulloblastoma is the most common malignant central nervous system (CNS) tumor of childhood, with an annual incidence of about 0.5-0.8/100,000 in children younger than 19 years. (medscape.com)
  • Glioblastoma multiforme is the most common malignant primary central nervous system neoplasm in adults. (hindawi.com)
  • Acinic Cell Carcinoma A malignant glandular epithelial neoplasm consisting of secretory cells forming acinar patterns. (nih.gov)
  • Atypical teratoid/rhabdoid tumor of the central nervous system is a highly malignant neoplasm and that usually arises in the posterior fossa, survival from this is frequently poor. (karger.com)
  • Caldemeyer KS, Smith RR, Azzarelli B, Boaz JC: Primary central nervous system malignant rhabdoid tumor: CT and MR appearance simulates a primitive neuroectodermal tumor. (karger.com)
  • Agranovich AL, Ang LC, Griebel RW, Kobrisky NL, Lowry N, Tchang SP: Malignant rhabdoid tumor of the central nervous system with subarachnoid dissemination. (karger.com)
  • Neuroblastoma is the most common extracranial pediatric neoplasm and the third most common pediatric malignancy after leukemia and central nervous system (CNS) tumors. (medscape.com)
  • Amongst them, pediatric cancers and rare hematologic neoplasms are often covered by dedicated educational events, while rare adult solid cancers are hardly grouped together and approached as a collective group of neoplasms. (eso.net)
  • 2. Embryonal Tumors of the Central Nervous System: An Update. (nih.gov)
  • 4. Embryonal Tumors of the Central Nervous System with Multilayered Rosettes and Atypical Teratoid/Rhabdoid Tumors. (nih.gov)
  • 7. Embryonal Tumors of the Central Nervous System: From the Radiologic Pathology Archives. (nih.gov)
  • 10. Embryonal Tumors of the Central Nervous System: The WHO 2016 Classification and New Insights. (nih.gov)
  • 1] 'Multiforme,' which refers to a heterogenous histologic appearance and proliferation of multiple cell types, was abandoned from the revised nomenclature in the 2007 World Health Organization Classification of Tumors of the Central Nervous System, and is now simply called 'glioblastoma. (cancernetwork.com)
  • A diffuse or multifocal peripheral neuropathy related to the remote effects of a neoplasm, most often carcinoma or lymphoma. (harvard.edu)
  • In this study we examined whether the ALAD G177C polymorphism in the gene coding for ALAD is associated with risk of intracranial tumors of the brain and nervous system. (nih.gov)
  • Given that the ALAD G177C polymorphism affects the toxicokinetics of lead in the body, and that exposure to lead may increase the risk of adult brain tumors, we postulated a possible association of ALAD G177C genotype and risk of intracranial tumors of the brain and nervous system (hereafter referred to as brain tumors). (nih.gov)
  • Our goal is to provide insights into the prediction, prevention, and treatment of nervous system cancer and neurological disorders. (mdanderson.org)
  • Our research is supported by the Cancer Prevention and Research Institute of Texas (CPRIT), the Department of Defense Neurofibromatosis Research Program, The University of Texas System, the Gilbert Family Foundation, and Alex's Lemonade Stand Foundation. (mdanderson.org)
  • The term 'glioblastoma multiforme' was introduced in the 1926 classification system devised by Cushing and Bailey. (cancernetwork.com)
  • Nervous System Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings) . (uchicago.edu)
  • Using various genetically engineered mouse models of NF1, we aim to determine the cellular and molecular mechanisms underlying the neuronal activity-mediated nervous system neoplasms associated with NF1. (mdanderson.org)
  • The ICD-10-CM Neoplasms Index links the below-listed medical terms to the ICD code C72. (icd.codes)